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The current surge of interest in postural orthostatic tachycardia syndrome commonly 
known as POTS requires good knowledge of the very complex physiology involved, 
but this is currently lacking. The often overlooked normal physiology of orthosta-
sis is reviewed including the definition of normal postural orthostatic tachycardia. 
An illustrated functional anatomy that embeds orthostatic tachycardia within the 
learned and skilful motor functions in the human population is presented. The four 
physiological phases of orthostasis and the role of tachycardia are described in a 
laboratory-controlled and progressive orthostatic stress in normal human volunteers. 
Standardized surrogate measures of autonomic control were used to quantify the trig-
ger level for excessive tachycardia and the minimum autonomic control required 
to sustain viable arterial blood pressure during severe orthostatic stress in normal 
human volunteers. Tachycardia during orthostasis is part of a “democratic” contri-
bution by four cardiovascular parameters of which the chronotropic function of the 
heart is just one of the parameters contributing toward cardiovascular compensation. 
It is adjusted during orthostasis in proportion to contributions from the other three 
parameters, namely inotropic function of the heart, windkessel vascular resistance 
and venous vascular capacitance. The physiological effects of the two stressors dur-
ing orthostasis, gravity and isometric contraction of skeletal muscles are reviewed. 
A model of how the four cardiovascular parameters are regulated during orthosta-
sis to achieve proportionate contributions is proposed emphasizing the necessity to 
quantify individual contributions from all these four parameters. Any one or more 
of these parameters may be compromised due to disease requiring disproportionate 
contribution of the prevailing magnitude of orthostatic tachycardia in an individual. 
It therefore requires neurophysiological assessment of the autonomic regulation of 
all the four cardiovascular parameters to assess the condition fully. We recommend 
here some current and novel neurophysiological methods that use modern medical 
technology to quantify laboratory standardized surrogate measures of some of these 
cardiovascular parameters including central parasympathetic regulation in postural 
orthostatic tachycardia syndrome.
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1 |  INTRODUCTION
1.1 | The aim of this review
The current surge of interest in the disease known as Postural 
Orthostatic Tachycardia Syndrome or POTS has disen-
franchized the natural and normal physiological status of 
cardiovascular compensations during mild and severe or-
thostatic stress. Although the disease POTS is a recognized 
dysautonomia, the whole phenomenon of postural orthostatic 
tachycardia has so far been turned into a popular disease due 
to lack of full knowledge of the complex but perfectly normal 
and natural physiology involved. The aim of this review is 
to restore the understanding of the natural and physiological 
basis of tachycardia during orthostasis (POT). This review 
will define the normal and natural POT in terms of a nor-
mal physiological phenomenon that can be reproduced in a 
normal human population in a physiology laboratory. The 
natural forces that exert the orthostatic stress that generates 
tachycardia in the human population are also presented. The 
functional arrangement of the neurons that generate tachy-
cardia in POT in the human population (the functional anat-
omy) is presented for the first time in order to demonstrate 
the natural origin POT in humans. This review includes a 
four-parameter model of cardiovascular compensation dur-
ing orthostasis in humans and how they can be assessed in a 
clinical laboratory to investigate the disease POTS.
1.2 | Definition of postural orthostatic 
tachycardia
1.2.1 | Origins of words
The phrase “Postural Orthostatic Tachycardia” refers to the 
quickening of heartbeats in response to a change in the posi-
tion of the body, usually from recumbent to an upright posi-
tion. The adjective postural has the Latin origin “positura” 
meaning position and the adjective orthostatic originates 
from two Greek words; “orthos” meaning upright and “sta-
tos” meaning standing. Hermann Lebert who was a physi-
cian introduced the term tachycardia in medicine in 1867. 
Tachycardia comes from two words of different origins, an 
English word “tachy” which means swift and the Greek word 
“kardia” which means the heart. Tachycardia literally means 
“swift heart”. Orthostasis is a verb meaning standing upright 
without translational movements, indicating clearly that the 
position of the subject is not shifting relative to the ground 
on which he or she is standing. It is very important to care-
fully define the phrase “postural orthostatic tachycardia" so 
that we understand fully that it actually refers to a natural and 
normal response of the heart to various and often numerous 
challenges to the human body during orthostasis. These chal-
lenges will be discussed later in this review.
1.2.2 | Sequence of events that defines 
postural orthostatic tachycardia
The heartbeat can start to quicken early during the thought 
of changing body position, even before the body begins to 
move (Figure  1). It is an indication that the heart receives 
cues from diverse sources to respond to orthostasis in addi-
tion to the body movements relative to the ground. The rate 
of heartbeats, commonly referred to as the heart rate, changes 
continuously during orthostasis; starting with the thought of 
righting the body in the erect posture and continues changing 
exceeding the time at which an upright posture is achieved 
to a period when the heart rate stabilizes at a rate faster than 
it was at the beginning of the process. We shall refer to 
this as early Phase 1 of orthostasis (Figure 1). The various 
magnitudes of heart rate changes at different stages of this 
early Phase 1 of orthostasis until it stabilizes in a fully com-
pensated cardiovascular state are well known and are used 
for detection of abnormalities associated with autonomic 
dysfunctions (Neilson, Ewing, Campbell, & Clarke,  1978) 
sometimes referred to as dysautonomia. This is what makes 
it important to accurately define both the stages and phases 
of orthostasis together with the range of normal magnitudes 
of changes in heart rate during these phases in order to use 
them as clinical tools for detecting diseases. For example, 
the ratio of the durations of cardiac cycles measured as in-
tervals of electrocardiographic R-waves during the trough of 
the rebound bradycardia and the peak of the tachycardia in 
the early Phase 1 of orthostasis is used to assess autonomic 
functions and is called the 30:15 ratio (Neilson et al., 1978). 
This test is called 30:15 ratio simply because the trough of 
the rebound bradycardia usually comes at or near the 30th 
heartbeat while the peak of the ramp tachycardia comes at 
or around the 15th heartbeat after achievement of the upright 
stance during orthostasis (Figure 1).
The heart rate is expected to stabilize and remain within 
a known normal range that is higher than it was in supine 
position for as long as the person maintains an upright 
stance without translational movement. This is known 
as Postural Orthostatic Tachycardia and the complex but 
K E Y W O R D S
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normal physiological processes involved in achieving this 
is the subject of this review. A person overwhelmed by the 
orthostatic challenge and develops neurological symptoms 
like poor balance or lack of spatial awareness, or cardiac 
symptoms like weakness or palpitations, is described as 
having poor or sometimes total lack of orthostatic toler-
ance. The extreme of orthostatic intolerance is postural 
syncope.
1.2.3 | Standardized diagnostic maneuvers
Diagnostic orthostatic challenge can be achieved by asking 
the patient to rise up to an erect posture starting from a su-
pine position (Kahn, 1988). There is a longer delay between 
the initiation of this process and eventual achievement of 
an upright posture in this method and it is also associated 
with increased signal noise during the process of changing 
posture. There is, however, a modified diagnostic maneuver 
where the patient is asked to rise up while seated on a low 
stool. This has a similar cardiovascular effect but with little 
signal noise and very short delay between the initiation and 
achievement of the upright posture (Julu & Hondo,  1992). 
The third and most common method is achieved using a tilt 
table. The patient will lie limply on the tilt table while being 
tilted at various angles starting from a horizontal supine po-
sition to 60° recline or up to 90° upright posture depending 
on the wish of the clinician. This is discussed in more de-
tail elsewhere. The physiological differences between these 
standardized diagnostic orthostatic challenges will become 
clearer later in this review.
1.3 | Functional anatomy of 
postural orthostatic tachycardia
1.3.1 | Organotopic organization of neurons
Early lessons from animal studies
Ablation plus nonspecific near-neuron stimulation tech-
niques showed that there were distinctive tachycardia and 
bradycardia zones in the brainstem and were called tachycar-
dia or bradycardia centers in those days (Alexander, 1946). 
The rostral part of medulla oblongata was largely excitatory 
and the caudal part was largely inhibitory according to the 
responses of blood pressure, heart rate, and sympathetic out-
flow recorded from peripheral nerves. The rostral medulla 
was therefore referred to as the "pressor" or “vaso-active" area 
F I G U R E  1  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters. 
Heart rate (HR) expressed in beats.min−1; systolic (SBP), diastolic (DBP) and mean arterial blood pressures (MAP) measured in mmHg; cardiac 
sensitivity to baroreflex (CSB) measured in ms.mmHg−1 and cardiac vagal tone (CVT) measure in units of a linear vagal scale (LVS) (see text for 
descriptions and methods used to measure these cardiovascular parameters). The command to stand up was given at (a) triggering CSB withdrawal. 
CVT withdrawal started concurrently with a ramp tachycardia 10 s later than the “stand up” command at (b). The subject achieved an upright stance 
8 s after the beginning of the ramp tachycardia at (c). The ramp tachycardia came to an abrupt end at (d) lasting for 19 s. The rebound bradycardia 
that followed ended at (e) and the HR recovered to a stable level in the upright stance at (f). Cardiovascular compensation with stable HR in the 
upright stance was achieved within 128 s (from c to f)
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while the caudal part of medulla was referred to as “depres-
sor” or vaso-reflex area of the brainstem (Alexander, 1946).
Rostral ventrolateral medulla (RVLM). Very early work 
in Carl Ludwig's laboratory had previously suggested that 
rostral medulla is a vasomotor center with automaticity with 
possible reflexogenic input (Seller, 1996). The development 
of microelectrodes that allow recording signals from 
single nerve fibers greatly improved our understanding of 
the organization of neurons in the brain, learning mainly 
from animal studies (Dampney, Blessing, & Tan,  1988). 
Glass tube microelectrodes facilitated microinjection of 
various known neuronal stimulants and enabled differential 
activation of neurons within the same area in the brain. This 
technique enabled categorization of neurons according to the 
neurotransmitters they use for communication (Boscan, Allen, 
& Paton,  2001; Sasaki & Dampney,  1990). Topographic 
arrangement of neurons in the brainstem controlling 
distinct and specific vascular beds has been described in the 
subretrofacial (SRF) region of the medullo-pontine junction 
(Dampney & McAllen, 1988; McAllen & Dampney, 1990). 
The old vasomotor area is currently known as the rostral 
ventrolateral medulla (RVLM) where tonically active pre-
sympathetic neurons are situated (Guyenet, Haselton, & 
Sun,  1989). It is also now well established in animals that 
these pre-sympathetic neurons are topographically organized 
according to their target-organs in various vascular beds 
independent of the somatic map (McAllen & Dampney, 1990). 
The topography of the pre-sympathetic neurons controlling 
various independent target-organs that has so far been 
described in the RVLM in animal studies are depicted in the 
human brainstem in Figure 2. We shall in this review describe 
the topographic organization of pre-sympathetic neurons in 
the RVLM as "Organotopic” organization meaning that the 
neurons are organized according to the target-organs they 
control independently of the somatic map or which side of 
the body. The importance of the central autonomic regulation 
sites (CARS) shown in Figure 2 will become clearer later on 
in this review.
Takeaway points
1. The topographic arrangement of neurons in the RVLM 
is according to the target-organs or some preset vas-
cular beds they control and this is independent of the 
sides of the body whether left or right and we call this 
organotopic organization of neurons.
2. These organotopic neurons control their target-organs 
through a common tonic vasomotor and sympathetic path-
way (Figure 2) descending from the RVLM through the 
spinal cord to the multiple target-organs they regulate in 
the body.
3. The tonic vasomotor supply to blood vessels in the body 
leaves the spinal cord at every segment starting from 
thoracic segment number one (T1) and it completes its 
exit out of the spinal cord at the level of thoracic segment 
number five (T5) in human (Nathan & Smith, 1987) and 
(Figure 2).
4. A central autonomic regulation site (CARS) is a distinct 
area of the brain that regulates several functions of the 
autonomic nervous system. For example, the RVLM is a 
discrete area in the brainstem that regulates several auto-
nomic functions and it is situated in a CARS site labelled 
as number 1 just for identification purposes only in this 
review. More of these regulatory sites and their identifica-
tion numbers are shown in Figure 2.
Caudal part of medulla oblongata. Functional 
organization of neurons in the caudal part of the medulla 
that was previously described as the bradycardia center 
is fully reviewed elsewhere (Gourine, Machhada, Trapp, 
& Spyer, 2016). The ventrolateral part of caudal medulla 
oblongata (cVLM) contains a network of neurons situated 
in separate and discrete nuclei in the caudal part of the 
brainstem. The arterial baroreceptor input through the 
ninth cranial nerve (IX) into the part of the brainstem 
depicted as bradycardia center in Figure 2 has first order 
synapses in the nucleus of tractus solitarius (NTS) (Lipski, 
McAllen, & Spyer,  1975). These baroreflex neurons are 
located in the medial nuclei of NTS in animals (Czachurski, 
Lackner, Ockert, & Seller, 1982) but the arrangement and 
architecture of neurons in the NTS are similar in human 
(McRitchie & Törk,  1993). The baroreflex neurons in 
the NTS project to neurons situated both in the RVLM 
and to a group of neurons located in the caudal part of 
nucleus ambiguus (NA) in the cVLM (Schreihofer & 
Guyenet,  2002). These are known as the cardiac vagal 
preganglionic neurons (cVPN). These cVPN in the caudal 
part of NA are the major source of the tonic parasympathetic 
negative chronotropic efferent to the heart and they have 
large myelinated B-fiber axons projecting to the nodal 
tissues of the heart (McAllen & Spyer, 1976). The cVPN of 
NA have tonic activities, which mainly have cardiac pulse 
rhythms but they also have and do respond to respiratory 
rhythms (Gilbey, Jordan, Richter, & Spyer,  1984). There 
is another independent source of tonic parasympathetic 
efferent to the heart originating from the caudal part of 
dorsal vagal motor nucleus (DVMN). The cVPN situated 
in the caudal part of DVMN have tonic rhythms that do 
not respond to baroreflex, respiration or chemoreceptor 
stimulations (Jones, Wang, & Jordan, 1998). These cVPN 
of DVMN have pacemaker-like activity with baseline 
firing rate between 0.5 and 6  Hz (Ballanyi, Doutheil, & 
Brockhaus,  1996), and they have slow unmyelinated 
C-fiber axons projecting to the heart (Ford, Bennett, Kidd, 
& McWilliam, 1990). Stimulation of the left vagus nerve 
trunk has negative inotropic effect in human, causing 
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load-independent reduction of ventricular contractility as 
measured by the end-systolic elastance (Lewis et al., 2001). 
The negative inotropic effect of stimulating the left vagus 
nerve trunk is blocked by the muscarinic antagonist 
glycopyrronium (Lewis et al., 2001). Since intra-coronary 
administration of atropine enhances dobutamine-induced 
inotropic responses of the left ventricle without affecting 
heart rate in human, but this effect is lost in denervated 
transplanted hearts (Landzberg, Parker, Gauthier, & 
Colucci, 1994), it is further evidence that there is a tonic 
parasympathetic restraint of the inotropic function of the 
heart in human coming from the cVPN of DVMN. This 
tonic parasympathetic ventricular restraint also regulates 
ventricular excitability as measured by effective refractory 
period, the threshold of triggered ventricular tachycardia 
and QT interval prolongation (Machhada et  al.,  2015, 
2016). The cVPN of DVMN are critically important 
for the recruitment of innate mechanisms of inter-organ 
protection underlying the phenomenon of remote ischemic 
conditioning (Mastitskaya et al., 2012) in which the heart 
is protected from myocardial ischemia and reperfusion 
injury by episodes of ischemia and reperfusion injuries 
F I G U R E  2  The mid sagittal section of the brain and the spinal cord used here for schematic illustration of the functional anatomy of postural 
orthostatic tachycardia. Electrocardiogram (ECG) and the arterial blood pressure waveform (BP waveform), both of which are generated by the 
heart, are the only two cardiovascular biometrics used to derive all the cardiovascular parameters displayed on the NeuroScope screen (see Figure 
12 and main text for details). The Roman numerals show the ninth (IX) and tenth (X) cranial nerves. These are the most important nerves in 
the generation of central parasympathetic cardiovascular regulation and they provide the only tonic parasympathetic supply for the whole body 
in humans. These two cranial nerves communicate with the bradycardia area (Bra) in the caudal part of medulla oblongata and the tachycardia 
area (Tac) in the rostral part of the medulla (RVLM). Skeletal muscles vascular bed provides the most of the windkessel vascular resistance, 
while the visceral (or splanchnic) vascular bed provides the most of the venous vascular capacitance, but the sympathetic supply to the skin is 
largely suppressed during orthostasis (see main text for more details). These three vascular beds are important for arterial blood pressure defense 
during orthostasis. Animal studies show that there are organotopic neurons, which are discrete and separate groups of neurons in the RVLM that 
specifically regulate sympathetic supplies to the skin (Skn), skeletal muscles (Mcl), and the visceral (Gut) vascular beds. There are also organotopic 
neurons within the RVLM regulating catecholamine release (Cat) and sympathetic supply to the kidney (Ren). The Arabic numerals (1–14) within 
the brain and the brainstem show the central autonomic regulation sites (CARS) that have been described during functional magnetic resonance 
imaging (fMRI) and positron emission tomography (PET) studies of central autonomic functions. These are large sites in the brain that regulate 
several autonomic functions and some of the connections shown between the different CARS sites are based on animal studies (see main text for 
more details). The Arabic numerals (1–12) beside the spinal cord indicate the respective thoracic segments. The tonic vasomotor supplies to the 
three major vascular beds come out of the spinal between T1 and T5
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in other tissues elsewhere in the body remote from the 
heart. The DVMN receives numerous modulatory inputs 
through the tenth cranial nerve (X, Figure  2) shown as 
vagal afferents, some of which has subdiaphragmatic 
origin, but all pass via the NTS to DVMN (Powley, 2000). 
There are also projections from hypothalamic nuclei in 
CARS site 3 and other forebrain areas like CARS sites 
9 and 8 with modulatory inputs from the periaqueductal 
gray (PAG) matter in CARS site 7 (Figure  2) through 
the descending pathway in CARS site 2 directly to the 
DVMN at the caudal medulla schematically depicted 
as bradycardia area (Figure  2). These rich modulatory 
inputs are shared between the cVPN including those in the 
caudal part of DVMN (Powley, 2000). The supramedullary 
modulation of cVPN can be used to reduce the extent 
of lethal ischemia and reperfusion injury of the heart 
either via recruitment of direct cardiac projections with 
consequent myocardial acetylcholine release (Mastitskaya 
et  al.,  2012) or via triggering the production and release 
into the systemic circulation of certain gut hormones 
thought to have cardioprotective properties (Mastitskaya 
et  al.,  2016). Experimental evidence available suggests 
that the cardioprotective gut hormone(s) are released by 
the visceral organ(s) innervated by the posterior gastric 
branch of the vagus nerve and is abolished by cutting this 
nerve (Mastitskaya et al., 2016) showing the significance 
of DVMN in this process. There are therefore two tonic 
parasympathetic outputs originating from two different 
types of cVPN in the caudal part of the brainstem destined 
to the heart through a common pathway, which is the 
vagus nerve (Figure 2). One tonic parasympathetic output 
controls the chronotropic functions of the heart while the 
other tonic parasympathetic output controls the inotropic 
and excitability functions of the myocardium.
Takeaway points
1. A network of three discrete nuclei in the cVLM in 
CARS site 1 forms the only central source of tonic 
parasympathetic supply for the whole body. These nuclei 
are NTS, caudal parts of NA and DVMN.
2. The vagus nerve provides a common and the only path-
way for two different types of outputs of tonic para-
sympathetic supplies from the brainstem to peripheral 
organs.
3. There are three types of rhythms that can be used to 
distinguish the origins of the two types of tonic central 
parasympathetic activities. The central parasympathetic 
tone with pacemaker-like rhythm varying in frequen-
cies between 0.5 and 6 Hz, and does not respond to res-
piratory chemoreceptor stimulation, cardiac pulsation, 
nor breathing rhythm, is generated by cVPN in DVMN. 
The central parasympathetic tone with inherent cardiac 
pulse and breathing rhythms and responds to respiratory 
chemoreceptor stimulation and also responds to voluntary 
changes in breathing rhythms is generated by cVPN in 
NA.
Lessons from functional magnetic resonance images 
(fMRI) studies in human
Invention of magnetic resonance imaging (MRI) of the 
brain that uses blood oxygen level dependent (BOLD) 
signal intensity (Ogawa, Lee, Nayak, & Glynn, 1990) has 
facilitated acquisition of useful and real-time functional 
images (fMRI) of the human brain in three dimensions. 
The BOLD signal intensity can therefore be correlated 
with different brain functions being investigated in real-
time during various tasks. This has been used to investi-
gate the brain areas regulating sympathetic activities at 
rest and during various maneuvers commonly deployed to 
challenge the autonomic nervous system during clinical 
examinations.
Baseline regulation of skeletal muscle sympathetic activity 
in supine position. Baseline brain control of the activities 
of sympathetic nerves running within peripheral nerves 
and destined to skeletal muscles was investigated at rest 
in supine position (Macefield & Henderson, 2016). BOLD 
signal intensity showed that at complete rest in supine 
position, the active brain sites controlling the skeletal 
muscle sympathetic activity (MSNA) in peripheral nerves 
were CARS sites 13, 11, 8, 6, 3, and 1 (Figure 2). CARS 
sites 3, 6, and 8 are part of the limbic system while CARS 
site 11 is in the premotor area of the frontal lobe and 
CARS site 13 is in the precuneus cortex in the parietal lobe 
(Catani & Dell’Acqua, 2013). The limbic system controls 
emotion, memory and behaviors, while the premotor 
cortex is a supplementary motor cortex for learned and 
skilful motor activities and the precuneus cortex serves as 
a self-consciousness and self-processing area of the brain 
required in activities that involves self-awareness (Catani 
& Dell’Acqua, 2013). The inhibition or restraint of MSNA 
at rest in supine position comes from only two CARS 
sites; 8 and 1, which means one CARS site in the limbic 
system and another in the brainstem and these two sites are 
active during both stimulation and inhibition of MSNA at 
rest in supine position. The pattern of central autonomic 
regulation shows bilateral and symmetrical activation of 
the precuneus cortex at CARS site 13, dorsolateral parts of 
the frontal lobe at CARS site 11 (the premotor area of the 
cortex), the posterior cingulate gyrus at CARS site 6, the 
ventromedial hypothalamus at CARS site 3 and the RVLM 
at CARS site 1 during bursts of MSNA at rest (Macefield 
& Henderson,  2016). Brain CARS site 8 comprises mid 
temporal lobe including uncus, entorhinal cortex and the 
parahippocampal gyrus. It also includes insula cortex, 
amygdala and hippocampus nuclei. There was asymmetric 
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contralateral antagonism in central autonomic regulation 
indicated by activation of MSNA by the left mid-insula 
cortex in CAR site 8 and inhibition of MSNA by the right 
ventral insular cortex also in CAR site 8 at rest in supine 
position (Macefield & Henderson, 2016). Brain CARS site 
3 is in the hypothalamus and the ventromedial part that 
receives signals from CARS sites 8 and 9 (Figure 2) was 
active bilaterally as discussed before, but the dorsomedial 
part that receives signals from CARS sites 11 and 13 was 
only active on the left side during bursts of MSNA. It means 
CARS site 3 has a complex pattern of central autonomic 
regulation where one part of the site has bilateral and 
symmetrical activity but another segment of the same 
site shows unilateral activity during central autonomic 
regulation at rest in supine position. Brainstem CARS site 
1 consists of rostral and caudal medulla oblongata as has 
been described before. There was bilateral and symmetrical 
inhibition and restrains of the bursts of MSNA by the 
cVLM and NTS. This is consistent with what has been 
observed and described in lower animals that the RVLM 
activates but the caudal medulla depresses or inhibits 
sympathetic activities especially the vasomotor tone and 
NTS is involved in this inhibition.
Takeaway points
1. Central activation of muscle sympathetic nerves at rest 
in supine position is symmetric and bilateral and comes 
from multiple sites in both upper and lower cortices 
of the cerebrum and from the brainstem. The premotor 
cortex of the frontal lobe and the precuneus cortex in 
the parietal lobe participate jointly in the symmetric 
activation from the upper cerebrums. The posterior cin-
gulate cortex and the ventromedial hypothalamus, both 
of which are within the limbic system, together with 
the RVLM in the brainstem are the subcortical sites for 
symmetric and bilateral activation of MSNA at rest in 
supine position. These CARS sites are represented in 
Figure  2 as 13, 11, 6, 3, and 1.
2. There is, in addition, a unilateral activation site in the left 
dorsomedial hypothalamus within the limbic system. This 
is CARS site 4 in Figure 2.
3. There is asymmetric contralateral antagonism within the 
insular cortex in the limbic system where the left mid-
insular cortex participates in the activation but the right 
ventral insular cortex inhibits MSNA at rest in supine po-
sition. This is in CARS site 8 in Figure 2.
4. The main inhibition and restraint of MSNA at rest in su-
pine position are from the brainstem in CARS site 1. This 
inhibition is bilateral and symmetrical and comes from the 
cVLM and NTS in the brainstem, both of which are situ-
ated in CARS site 1. This pattern of sympathetic regula-
tion at the brainstem is identical to that described in lower 
animals including rodents.
Baseline regulation of cutaneous sympathetic activity in 
supine position. Baseline brain control of the activities 
of sympathetic nerves running within peripheral nerves 
and destined to the skin was investigated at rest in supine 
position (Macefield & Henderson,  2016). BOLD signal 
intensity showed that at complete rest in supine position, 
the active brain sites controlling the cutaneous sympathetic 
activity were CARS sites 13, 10, 9, 8, 6, and 4 (Figure 2). 
The inhibition or restraint of cutaneous sympathetic activity 
at rest in supine position came unilaterally from only one 
site and that is CARS site 9 on the left side of the brain. 
There were no involvements of CARS sites 3 and 1 in the 
regulation of cutaneous sympathetic activity at rest in supine 
position. The pattern of central autonomic regulation showed 
bilateral and symmetrical facilitation from CARS site 13 in 
the precuneus cortex and CARS site 6 in the mid cingulated 
cortex. There is asymmetric but bilateral facilitation in CARS 
site 8 arising from the right anterior insula cortex and the left 
posterior insula cortex. Unilateral facilitations are from the 
right anterior prefrontal cortex in CARS site 10 and the left 
ventro-medial thalamus in CARS site 4. There is contralateral 
antagonism arising from CARS site 9 at rest in supine position 
in which facilitation of cutaneous sympathetic activity came 
from the right orbitofrontal cortex and inhibition came from 
the left orbitofrontal cortex.
Takeaway points
1. Central regulation of cutaneous sympathetic activity at 
rest is within the limbic system and is restricted to 
supra-medullary sites with little or no involvement of 
CARS sites below the aqueduct of sylvius.
2. There is only one unilateral CARS site for restraining 
cutaneous sympathetic activity at rest involving the con-
tralateral antagonism in CARS site 9 where the left orbito-
frontal cortex inhibits and the right orbitofrontal cortex 
facilitates.
3. There is symmetric and bilateral facilitation of cutaneous 
sympathetic activity at rest coming from the precuneus 
cortex in CARS site 13 and lower down from the mid cin-
gulate cortex in CARS site 6.
4. There is asymmetric but bilateral facilitation of cutaneous 
sympathetic activity from CARS site 8 coming from the 
right anterior insula and the left posterior insula cortices.
5. There are, in addition, unilateral facilitations of cutaneous 
sympathetic activity coming from right anterior prefrontal 
cortex in CARS site 10 and the left ventro-medial thala-
mus in CARS site 4.
Central autonomic regulation of heart rate in response 
to mild and moderate passive lower body venous pooling 
with no change in blood pressure
The BOLD signal intensity showed that at complete rest 
in supine position the CARS sites responding to mild 
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lower body venous pooling without change in blood pres-
sure caused by lower body negative pressure (LBNP) of 
−15 mmHg, equivalent to a drop in central venous pressure 
(CVP) from 7  mmHg to 5  mmHg (Kimmerly, O’Leary, 
Menon, Gati, & Shoemaker,  2005) and moderate lower 
body negative pressure (LBNP) of −35 mmHg, equivalent 
to a drop in CVP from 7 mmHg to 3.7 mmHg with signifi-
cant increases in both heart rate (up to 112%) and MSNA 
(up to 300%) but without significant increase in blood pres-
sure (Kimmerly et al., 2005) are 4, 6, 7, 8, 9, 10, 11, 12, 13, 
and 14 (Figure 2).
Pattern of central autonomic regulation in response to lower 
body venous pooling. The heart rate has tonic, symmetric, 
and bilateral restraint within the limbic system coming from 
the anterior cingulate cortex in CARS site 6, anterior insular 
cortex in CARS site 8, the amygdala in CARS site 8 and the 
medial dorsal nucleus of thalamus in CARS site 4 during mild 
LBNP. There is an additional unilateral restraint coming from 
the right orbitofrontal cortex in CARS site 9 (Figure 2). These 
tonic restrains are withdrawn in a complex pattern in response 
to mild LBNP. There is appropriate and bilateral reduction of 
the restrains from the anterior cingulate and anterior insula 
cortices, but are associated with unilateral withdrawals of the 
restraints from the left dorsal medial nucleus of the thalamus, 
the left amygdala and the right orbitofrontal cortex. However, 
the specific autonomic drive of heart rate in response to mild 
lower body venous pooling is unilateral and comes from the 
right side of CARS sites 8, 11, 12, and 14 (Figure 2). These 
are the right posterior insular cortex in CARS site 8, the right 
premotor cortex of the frontal lobe in CARS site 11, the right 
post-central gyrus in CARS site 12 and the cerebellum in 
CARS site 14. Mild lower body venous pooling also provokes 
simultaneous unilateral autonomic drives mainly from the 
right frontal lobe to the cardiovascular system. The right 
prefrontal cortex in the inferior frontal gyrus in CARS site 
10, right middle frontal gyrus in CARS site 11, right fronto-
parietal gyrus in CARS site 12, the right precuneus cortex 
in CARS site 13, and the left cerebellum in CARS site 14 
(Figure 2) are all involved in providing the autonomic drives 
to the cardiovascular system in response to mild lower body 
venous pooling leading to a nonsignificant increase in the 
heart rate, but a significant increase in MSNA up to 192% 
without change in blood pressure (Kimmerly et  al.,  2005). 
These unilateral autonomic cardiovascular drives are 
intensified during moderate lower body venous pooling. 
Other parts of the frontal lobe with asymmetric but bilateral 
activities are the dorsolateral prefrontal cortices involving the 
left Brodmann area 46 within CARS site 10 and the right 
Brodmann area 9 also still within CARS site 10 (Figure 2). 
The symmetric and bilateral autonomic restraint within the 
limbic system is also upgraded during response to moderate 
compared with mild lower body venous pooling. There is, in 
addition, a unilateral withdrawal of the autonomic restraint 
coming from the right periaqueductal gray matter in the 
midbrain in CARS site 7 in response to moderate lower body 
venous pooling leading to the significant increases in heart 
rate and MSNA described above, but no significant increase 
in mean arterial blood pressure.
Takeaway points
1. Chronotropic function of the heart in humans is facil-
itated predominantly from multiple sites on the right 
side of the brain by specific groups of neurons with 
organotopic spatial arrangements. Recruitment of similar 
sites from the left side of the brain is used to upgrade 
chronotropic facilitation when there is significant increase 
of cardiovascular stress above baseline.
2. Current fMRI evidence suggests that the chronotropic 
drive from the brain comes from organotopic neurons situ-
ated within the premotor area of the frontal lobe, which is 
the general area responsible for the execution of learned 
and skillful motor activities. These chronotropic organo-
topic neurons are in CARS site 11 (Figure  2) and they 
are activated in synchrony with somatosensory neurons in 
the right CARS site 12. The right posterior insula cortex 
in CARS site 8 and the left cerebellum in CARS site 14 
(Figure  2) also provide chronotropic drive. It therefore 
means altogether CARS sites 8, 11, and 14 provide the 
major chronotropic drive synchronized with somatosen-
sory activation in CARS site 12 in response to lower body 
venous pooling.
3. Chronotropic function of the heart in humans is restrained 
and modulated for appropriateness and magnitude within 
the limbic system, which is also responsible for memory, 
emotion, and behaviors among other functions. This re-
straint, which extends to the periaqueductal gray matter in 
the midbrain, has to be subdued or reduced substantially 
during significant increase of cardiovascular stress above 
baseline. It is known that the periaqueductal gray matter 
modulates responses to threatening stimuli.
4. Current fMRI evidence suggests that the left amygdala, 
left medial dorsal nucleus of the thalamus and the right 
anterior cingulate cortex have groups of neurons with or-
ganotopic spatial arrangements and these neurons specifi-
cally restrain and modulate chronotropic function of the 
heart. Recruitment of similar sites from the opposite side 
of the brain is used to remove or substantially reduce the 
chronotropic restraint and modulation when there is a sig-
nificant increase of cardiovascular stress above baseline. 
This recruitment to reduce the extra capacity for restraint 
is extended to the right posterior–inferior insula cortex and 
the left periaqueductal gray matter. It therefore means the 
restraint and modulation of chronotropic function of the 
heart in response to moderate lower body venous pooling 
normally comes from CARS sites 4, 6, 7, and 8 (Figure 2).
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5. General autonomic drive in response to lower body ve-
nous pooling comes from the frontal lobe in CARS sites 
12, 11, and 10 (Figure 2) and is closely monitored by the 
right precuneus cortex in CARS site 13. The precuneus 
cortex is responsible for self-consciousness and self-pro-
cessing. Although there is asymmetric and bilateral au-
tonomic drive from the dorsolateral prefrontal cortex in 
CARS site 10 (Figure 2), the right premotor area in CARS 
site 11 is dominant in proving general autonomic drive, 
while the left side is recruited when there is significant 
increase of cardiovascular stress above baseline.
6. General autonomic restraint and modulation in response 
to lower body venous pooling comes from the limbic sys-
tem in CARS sites 6 and 8 (Figure  2). This is bilateral 
and symmetric and the restraint is substantially reduced 
mainly in the anterior insula and anterior cingulate cor-
tices when there is significant increase of cardiovascu-
lar stress above baseline. Extra capacity for reduction of 
general autonomic restraint and modulation in response 
to lower body venous pooling comes from the right orbito-
frontal cortex in CARS site 9 (Figure 2).
1.3.2 | Lessons from positron-emission 
tomography (PET) studies in human
Positron-emission tomography (PET) is a nuclear func-
tional imaging technique that is used to track metabolic 
processes in the body, usually in real-time. The system de-
tects pairs of gamma rays emitted indirectly by positron 
emitting radioligands like 18F in the form of fludeoxyglu-
cose (FDG), an analogue of glucose. The concentrations 
of this tracer when imaged in the body will indicate tissue 
metabolic activity and corresponds to the regional glucose 
uptake at that moment. Other radioligands like 15O in the 
form of water (H2
15O) is used to indicate changes in re-
gional blood flow in organs or tissues in the body. Three-
dimensional images of the tracer concentration within the 
body are constructed from gamma rays scanners by com-
puter analysis. This gamma rays image is superimposed 
onto three-dimensional images of the organ or the whole 
body acquired by other methods of scanning like x-ray 
computed tomography (CT), magnetic resonance imaging 
(MRI), functional magnetic resonance imaging (fMRI), 
and ultrasound.
Central autonomic regulation of chronotropic response to 
isometric contraction of skeletal muscles of the hand with 
significant change in heart rate
Chronotropic drive during isometric contraction of skeletal 
muscles. The active positive chronotropic organotopic 
neurons during isometric contraction of skeletal muscles 
are in CARS sites 14, 8, and 1 (Figure 2). Human subjects 
underwent H2
15O PET scanning while performing isometric 
contraction of skeletal muscles using their right hand and the 
heart rate (HR) was monitored during scanning (Critchley, 
Corfield, Chandler, Mathias, & Dolan,  2000). This study 
showed that in order to achieve a significant increase in 
HR, there are significant increases in blood flow in two 
cerebellar peduncles; the right inferior and the left middle 
peduncles carrying proprioceptive and vestibular inputs 
and outputs. This is associated with significant increases 
in blood flow only in the right retrofacial area in the lower 
pons within CARS site 1 and the left cerebellum in CARS 
site 14 and also in the right insula cortex in CARS site 8 
(Figure 2). This means although there are significant and 
bilateral increases of proprioceptive inputs into both left 
and right cerebella during unilateral isometric contraction 
of skeletal muscles in the right hand, only one cerebellum on 
the contralateral left side provides the heart with significant 
chronotropic drive, assisted by ipsilateral CARS sites in the 
right insula cortex and the brainstem tachycardia area also 
on the right side. It can be concluded that chronotropic 
drives come from the contralateral cerebellum in CARS 
site 14 on the left side and the ipsilateral insula cortex 
in CARS site 8 on the right side, and both act on the 
organotopic chronotropic neurons in the tachycardia area 
of the brainstem on the right side in CARS site 1 during 
isometric contraction of skeletal muscles in the right hand. 
Two of the supramedullary positive chronotropic CARS 
sites 14 and 8 are similar to what was observed above 
during lower body venous pooling.
Chronotropic restraint during isometric contraction of 
skeletal muscles. The active negative chronotropic 
organotopic neurons during isometric contraction of 
skeletal muscles are all within the limbic system in CARS 
sites 10, 9, 8, and 6 (Figure 2). The PET study discussed 
above shows significant and bilateral reduction of blood 
flow in the orbitofrontal cortices in CARS site 9. There 
are, in addition, significant reductions of blood flows in 
the left amygdala in CARS site 8, the right anterior and 
posterior cingulate cortex in CARS site 6 and the right 
middle frontal gyrus in the frontal eye fields in CARS 
site 10. This shows that the major chronotropic restraint 
applied to the heart during isometric contraction of skeletal 
muscles of the right hand comes from the left amygdala 
and the right anterior cingulate cortex in CARS sites 8 and 
6, respectively. These two negative chronotropic CARS 
sites are similar to what was observed above during lower 
body venous pooling. The PET study also shows that the 
orbitofrontal cortex in CARS site 9, which is involved in the 
regulation of sympathetic functions in the skin as discussed 
above, is significantly and bilaterally subdued in order to 
achieve significant increase in chronotropic function of the 
heart during isometric contraction of skeletal muscles.
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Central autonomic regulation of arterial blood pressure 
in response to isometric contraction of skeletal muscles of 
the hand with significant change in mean arterial blood 
pressure
Arterial pressure drive during isometric contraction of 
skeletal muscles. The arterial pressure drives come from 
CARS sites 14, 12, 10, 8, and 6 (Figure 2). Human subjects 
underwent H2
15O PET scanning while performing isometric 
contraction of skeletal muscles using their right hand and the 
mean arterial pressure (MAP) was monitored during scanning 
(Critchley et  al.,  2000). This study shows that in order to 
achieve a significant increase in MAP, there is significant and 
bilateral increase in blood flow in both left and right cerebella 
in CARS site 14. There are, in addition, increases in blood 
flows in the left primary somatosensory cortex at Brodmann 
area 2 in CARS site 12, the right anterior prefrontal cortex in 
CARS site 10, the right anterior insula cortex in CARS site 8 
and the right anterior cingulate cortex in CARS site 6. This 
means the two cerebella drive the increase in arterial blood 
pressure bilaterally with the assistance of the contralateral 
somatosensory cortex during unilateral isometric contraction 
of skeletal muscles on only one side of the body. There are 
additional drives from multiple sites within the limbic system 
on the ipsilateral side of the contracting muscles.
Restraints of the arterial pressure rise during isometric 
contraction of skeletal muscles. The restraints of arterial 
pressure increase during isometric contraction of muscles 
are from within the limbic system in CARS sites 9, 8, and 6 
(Figure 2). Human subjects underwent H2
15O PET scanning 
while performing isometric contraction of skeletal muscles 
using their right hand and the mean arterial pressure (MAP) 
was monitored during scanning (Critchley et  al.,  2000). 
This study shows bilateral reduction of blood flow in the 
orbitofrontal cortices in CARS site 9 associated with the rise 
in arterial pressure during isometric contraction of skeletal 
muscles. There are, in addition, unilateral and significantly 
reduced blood flows on the left side in the uncus in CARS 
site 8, the hippocampus in CARS site 8 and the posterior 
cingulate cortex in CARS site 6. On the right side there are 
reduced blood flows in the middle temporal gyrus in CARS 
site 8 and the parahippocampal gyrus also in CARS site 8. 
This again shows that the orbitofrontal cortex in CARS site 
9, which is also involved in the regulation of sympathetic 
functions in the skin as discussed before, is significantly and 
bilaterally subdued in order to achieve significant increase 
in arterial blood pressure during isometric contraction of 
skeletal muscles. The PET study also shows that there is 
asymmetric contralateral antagonism within CARS site 6 
where activity in the right anterior cingulate cortex increases 
with the rise in arterial blood pressure and the activity in the 
left posterior cingulate cortex is subdued or reduced at the 
same time. This means the limbic system bilaterally restraints 
the rise in arterial blood pressure during unilateral isometric 
contraction of skeletal muscles using mainly organotopic 
neurons in multiple areas situated within CARS sites 8 and 9.
Takeaway points
1. There are concurrent and significant increases in both 
heart rate and arterial blood pressure during isometric 
contraction of skeletal muscles even when there is no 
effort in performing the task, but the magnitudes of 
changes increase with efforts.
2. Propioceptive activation of the contralateral cerebellum in 
CARS site 14 provides positive chronotropic drive to the 
ipsilateral organotopic chronotropic neurons in the tachy-
cardia area of the brainstem in CARS site 1.
3. Somatosensory activation of the contralateral cerebral 
cortex in CARS site 12 in combination with propioceptive 
activation of both left and right cerebella in CARS site 
14 altogether drive the arterial blood pressure rise during 
isometric contraction of skeletal muscles.
4. The limbic system restrains and modulates the magnitudes 
of both the chronotropic effect and the arterial blood pres-
sure rise during isometric contraction of skeletal muscles 
through ipsilateral facilitations combined with bilateral re-
strains by organotopic neurons situated in different areas 
in CARS sites 10, 8, and 6.
5. The orbitofrontal cortices in CARS site 9, which are also 
known to regulate autonomic functions in the skin, are 
bilaterally and significantly subdued during isometric 
contraction of skeletal muscles to allow concurrent rise 
of both heart rate and blood pressure. Since the gradient 
of concurrent changes of arterial blood pressure and heart 
rate is a measure of baroreflex gain, it is evident that a 
major role of CARS site 9 is to set and maintain the central 
baroreflex gain during contraction of skeletal muscles.
1.4 | Physiology of orthostatic tachycardia
1.4.1 | A model of cardiovascular regulation 
to facilitate our understanding of the 
physiology of orthostatic tachycardia
We propose here a model of beat-to-beat cardiovascular regu-
lation based on the current knowledge of functional anatomy 
discussed in detail in the previous section (Figure  3). This 
model will be used to explain the regulatory changes during a 
laboratory-controlled and progressive increase in orthostatic 
stress leading up to failure of cardiovascular compensation 
and the beginning of pre-syncope with subsequent failure to 
maintain a physiologically viable arterial blood pressure dur-
ing orthostasis. All major cardiovascular parameters will be 
monitored and if possible quantified during the progressive 
orthostatic stress, particularly highlighting the role of the 
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heart rate in every step of cardiovascular compensation and 
during decompensation and subsequent failure to maintain 
a viable arterial blood pressure. This model will be used to 
explain the physiology behind excessive tachycardia during 
orthostasis in a normal human population.
1.4.2 | Proposed model of beat-to-beat 
cardiovascular regulation
The role of supramedullary CARS sites in this model
In the proposed model (Figure  3), all the supramedullary 
CARS sites starting from 3 to 14 (Figure 2) are considered 
together as processing sites with a common task to deliver 
to the brainstem autonomic drives that is appropriate for 
execution in a given physiological state of the body at that 
moment. The detailed discussion of functional anatomy in 
the previous section can be condensed to reflect that the 
supramedullary CARS sites use sensory inputs from the 
primary somatosensory areas of the cortex to process within 
the precuneus cortex, the self-awareness and self-conscious-
ness according to the prevailing physiological state. Crude 
autonomic drives in response to the prevailing physiologi-
cal states are activated from the premotor area of the frontal 
cortex assisted by the cerebellum. These crude autonomic 
drives are further modulated and refined by the limbic system 
through restrains and or additional stimulations and delivered 
for execution to appropriate organotopic neurons in CARS 
site 1 in the brainstem (Figure 2). There is bidirectional com-
munication between the brainstem and the supramedullary 
CARS sites (Figure 3) to facilitate feedback and further ad-
justments of the autonomic drives to match the continuously 
changing physiological state of the body.
The role of the brainstem in this model
The brainstem CARS site 1 is the major central beat-to-beat 
cardiovascular regulatory site in this model receiving the 
necessary beat-to-beat arterial baroreceptor input required 
F I G U R E  3  Proposed model of beat-to-beat cardiovascular regulation. The reflex negative feedback control is executed within the brainstem 
central autonomic regulation site (CARS) using arterial baroreceptor afferent and two efferent pathways A and B. The supramedullary CARS sites 
adjust the magnitude of the reflex regularly. The descending pathway A = vagus nerve with two tonic parasympathetic pathways that regulate 
inotropic and chronotropic functions of the heart in Zone C. B = the common sympathetic and vasomotor pathway descending in the spinal 
cord with the vasomotor efferent that regulates windkessel vascular resistance and venous vascular capacitance in Zone D. The venous vascular 
capacitance has afferent input to the brainstem CARS site coming from what are known as volume receptors. These mediate the Bainbridge 
reflex. The myocardium also has afferent input to the brainstem CARS site and this mediate the Bezold-Jarisch reflex. The resultant venous return 
emerging from capacitive vessels is transformed into cardiac output by the combined chronotropic and inotropic efforts of the heart. The combined 
effects of cardiac output into windkessel vessels and controlled drainage of blood away from the windkessel vessels by windkessel vascular 
resistance generate arterial blood pressure (see text for full description of the model). Medical technology is available for continuous and real-time 
measurements of the cardiovascular functions in the light blue boxes. Laboratory standardized surrogate measures of cardiovascular functions in the 
light coral boxes are also available
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for immediate cardiovascular adjustments (Figure  3). This 
means the regulatory target in this model is the arterial blood 
pressure and the effective perfusion pressure in a cardiac 
cycle is the mean arterial pressure (MAP). Therefore, the 
model proposes that a target MAP appropriate for the pre-
vailing physiological state is defended by continuous beat-to-
beat adjustments of the following cardiovascular functions: 
two cardiac functions, the inotropic and chronotropic con-
tractions of the heart (Zone C in Figure 3) are adjusted beat-
by-beat concurrently with two vascular functions; the total 
windkessel vascular resistance to regulate arterial drainage 
and the total venous vascular capacitance to regulate the vol-
ume of venous blood returned back to the heart commonly 
referred to as venous return (Zone D in Figure 3). The regu-
latory commands for beat-to-beat cardiovascular adjustments 
are delivered through two descending pathways originating 
from CARS site 1 in the brainstem (Figure 2). These are the 
common parasympathetic pathway in the vagus nerve (A in 
Figure 3) and the common sympathetic pathway in the spinal 
cord (B in Figure 3). The origins of these common autonomic 
pathways are discussed in detail in the previous section. Due 
to the organotopic arrangements of neurons in CARS sites 
discussed before, the regulation of chronotropic function of 
the heart is independent to that of its inotropic function and 
likewise, the regulation of windkessel vascular resistance to 
control beat-to-beat arterial drainage of blood is independent 
to the regulation of venous vascular capacitance to control 
beat-to-beat blood volume returned to the heart, or venous 
return.
The role of tachycardia in the beat-to-beat model of 
cardiovascular regulation
In an example discussed in the previous section above, mod-
erate lower body venous pooling induced by external nega-
tive lower body pressure reduced the central venous pressure 
to 50% of the initial normal resting value. Muscle sympathetic 
nerve activity (MSNA) increase to 300% of the initial resting 
value and the heart rate increased by 19% in order to success-
fully defend the resting supine MAP, which did not change 
significantly during the external negative lower body pres-
sure challenge. The reduced central venous pressure suggests 
that a reduction of the venous blood volume returned to the 
heart is the main cardiovascular stress in this example. The 
best way to have ascertained this would be to measure the car-
diac output during this study, but it was not done. However, 
reduced venous return could have been achieved by mechan-
ical manipulation of the venous vascular capacitance using 
negative pressure to suck, distend and enlarge the veins due 
to the much higher compliance of venous walls compared to 
arterial walls. Venous wall has about thirty times more com-
pliance than arterial wall (Gelman, 2008). Increased venous 
vascular capacitance caused by the mechanically distended 
veins causes venous pooling and reduces venous return. The 
increased MSNA represents an upgrade of the total windkes-
sel vascular resistance and the increased heart rate represents 
an upgrade of the chronotropic function of the heart in re-
sponse to this cardiovascular stress. Inotropic function of the 
heart is one other independent cardiovascular parameter pro-
posed in our model (Figure 3) but it was not monitored in this 
example. It is evident in this example that tachycardia is part 
of a compensatory mechanism used during cardiovascular 
stress involving reduced venous return.
1.4.3 | Two forces generate orthostatic 
cardiovascular stress
Gravity
Gravity creates vascular hydrostatic pressure, which is pro-
portional to the density of blood and the vertical height of the 
column of blood inside the blood vessel. Since gravitational 
force during orthostasis is downwards toward the center of 
the earth, the hydrostatic pressure in all the venous vascular 
system below the horizontal level of the heart is in opposition 
to venous return to the heart. Venous hydrostatic pressure fa-
cilitates pooling of blood within the veins due to the high 
compliance of venous vascular walls as discussed before. 
In other words, gravity increases the total venous vascular 
capacitance shown in Figure  3 in proportion to the verti-
cal heights of the respective venous vascular columns. The 
longer the vein, the greater is the potential gravity-induced 
increase in venous vascular capacitance in the upright posi-
tion. Increased venous vascular capacitance causes cardio-
vascular stress by reducing venous return thereby activating 
compensatory measures to counteract the stress in order to 
defend a target MAP appropriate for the prevailing physi-
ological state. The total gravity-induced increase in venous 
vascular capacitance is larger in the upright position com-
pared to the supine position. In an example of acute loss 
of gravity during a parabolic flight in an aeroplane, a brief 
loss of gravity-induced venous vascular capacitance during 
zero gravity lasting only 20 s caused a 23% increase in car-
diac output (Petersen, Damgaard, Petersen, & Norsk, 2011) 
equivalent to 23% increase in venous return in subjects sitting 
upright. Loss of gravity-induced venous vascular capacitance 
for the same duration increased cardiac output by only 11% in 
subjects lying in supine position (Petersen et al., 2011) equiv-
alent to 11% increase in venous return, which is about 50% 
of that observed in the sitting position. This example shows 
that gravity increases venous vascular capacitance to reduce 
venous return and cardiac output (Figure  3) and this grav-
ity-induced cardiovascular stress is more than twice as large 
when sitting in an upright position compared with the cardio-
vascular stress when lying in supine position. Cardiovascular 
compensatory mechanisms during reduced venous return 
involve tachycardia as discussed before in the example 
   | 13 of 29OKETA-ONYUT JULU
of venous pooling during lower body negative pressure. It 
therefore means gravity-induced tachycardia increases dur-
ing the change in body position from supine to upright. There 
are multiple organotopic neurons in supramedullary CARS 
sites involved in this positive chronotropic change, most of 
these CARS sites are on the right-hand side of the brain as 
discussed in the previous section. Gravity-induced reduc-
tion of venous return activates somatosensory neurons in the 
right CARS site 12 (Figure 2) concurrently with organotopic 
chronotropic neurons in the premotor area of the right frontal 
lobe in CARS site 11 (Figure 2). The contralateral left cer-
ebellum in CARS site 14 is also activated to provide positive 
chronotropic drive together with the modulations from the 
limbic system, which consist largely of the concurrent with-
drawal of baseline restraint from the amydala and facilitation 
from the right posterior insular cortex, altogether consti-
tute supramedullary chronotropic command to the organo-
topic cardioaccelerator neurons in the brainstem CARS site 
(Figure  3). Gravity-induced chronotropic commands from 
the brainstem targeting cardiac functions (Zone C, Figure 3) 
are delivered through two descending autonomic common 
pathways; one in the vagus nerve (pathway A, Figure 3) and 
the other in the spinal cord (pathway B, Figure 3). Detailed 
functional anatomy of autonomic response to reduced ve-
nous return is discussed in the previous section. It includes 
the significant increase in MSNA interpreted here to repre-
sent the adjustment of windkessel vascular resistance in re-
sponse to an increase in venous vascular capacitance (Zone 
D, Figure 3).
Takeaway points
1. Gravity increases the total venous vascular capacitance 
by creating hydrostatic pressure that distends the high 
compliance venous walls leading to pooling effect
2. Gravity-induced increase in venous capacitance holds 
back more than 10% of the cardiac output in the supine 
position in humans. This is however more than doubled 
in the upright position, when gravity-induced increase in 
venous capacitance holds back more than 20% of cardiac 
output even in an upright sitting position
3. Tachycardia is part of the natural compensatory mecha-
nism in response to reduced venous return and is used to 
defend the appropriate target arterial blood pressure re-
quired for the prevailing physiological state
Skeletal muscles contraction
The process of orientation to an upright stance and the bal-
ance to maintain the upright stance against gravity dur-
ing orthostasis involves contraction of skeletal muscles. 
These muscles are sometimes described as antigravity 
(Sherrington,  1910) or postural muscles. Postural muscles 
are enriched with slow-twitch or tonic muscle fibers for iso-
metric contraction (Ivanenko & Gurfinkel,  2018) and they 
include the large muscles in the neck, trunk and lower limbs. 
All muscle contractions, particularly isometric contractions, 
induce cardiovascular stress by creating sudden and large 
metabolic demand. Skeletal muscle metabolic demands sig-
nificantly stimulate the autonomic nervous system by concur-
rent removal or reduction of baseline restraints while actively 
exciting specific organotopic neurons in the brain including 
the brainstem as discussed before. Somatosensory inputs to 
the supramedullary CARS sites (Figure 3) arising from the 
contracting muscles and other organs include propiocep-
tive and vestibular inputs. These are the main drives of the 
autonomic nervous system during isometric contraction of 
skeletal muscles during orthostasis (see Functional Anatomy 
above). However, the organotopic cardioaccelerator neurons 
in CARS site 1 in the brainstem respond more closely to the 
propioceptive and vestibular inputs during isometric contrac-
tion of skeletal muscles and the responses are modulated by 
the limbic system as discussed before. The overall effects of 
the concurrent withdrawal of baseline autonomic restraint 
combined with stimulation of specific organotopic neurons 
in supramedullary CARS sites are to target and adjust cardiac 
functions (Zone C, Figure 3) and vascular functions (Zone 
D, Figure 3) to meet the new metabolic demand. This auto-
nomic command is transmitted to the organotopic neurons in 
the brainstem CARS site and executed through two descend-
ing autonomic common pathways (A and B, Figure 3) lead-
ing to simultaneous and significant increases in both arterial 
blood pressure and tachycardia. The magnitude of autonomic 
excitation during isometric contraction of skeletal muscles 
is related to the contracting muscle mass (Seals, 1989) and 
the gradient of concurrent increases in heart rate and arte-
rial blood requires significant reduction of the restraint from 
CARS site 9. The two simultaneous cardiovascular effects 
of isometric contraction of skeletal muscles are significant 
even when the muscle contractions are effortless as discussed 
above in Functional Anatomy. It is therefore evident that in 
order to achieve a proper resting baseline autonomic state, all 
skeletal muscles except the respiratory muscles, should be 
fully relaxed and the subject should be in a supine position 
for minimal gravitational cardiovascular stress.
Takeaway points
1. Antigravity skeletal muscles create cardiovascular stress 
during orthostasis by performing isometric contractions. 
This creates sudden and sustained increase in metabolic 
demand and a new physiological state that requires in-
creased arterial blood pressure is set up
2. Isometric contraction of skeletal muscles causes concur-
rent increases in arterial blood pressure and tachycardia 
caused by simultaneous withdrawal of baseline cardio-
vascular restraints and excitation of specific organotopic 
neurons in CARS sites in the brain, brainstem and the 
cerebellum
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3. The organotopic cardioaccelerator neurons in the brain-
stem CARS site respond more closely to the propriocep-
tive and vestibular inputs during isometric contractions of 
skeletal muscles
4. The magnitude of autonomic excitation during isometric 
contraction is related to the contracting skeletal muscle mass, 
but CARS sites within the limbic system, particularly CARS 
site 9, restrain the extents of concurrent increases in heart 
rate and arterial blood pressure during muscle contraction.
1.4.4 | Laboratory-controlled and 
progressive orthostatic stress
There are four phases of orthostasis revealed during a study of 
cardiovascular control during the period leading to pre-syn-
cope in patients with posturally related syncopal attacks (Julu, 
Cooper, Hansen, & Hainsworth,  2003). Briefly, men aged 
30–55 years (mean ± SEM, 35 ± 8 years) and women aged 
35–50 years (40 ± 5 years) volunteered in this study. All vol-
unteers did not have any known cardiovascular or neurologi-
cal disorders and were not taking any medications. Important 
beat-to-beat cardiovascular parameters including heart rate 
(HR) representing chronotropic function of the heart, systolic 
(SBP), diastolic (DBP), the mean arterial blood pressures 
(MAP), and forearm vascular resistance (FVR), all represent-
ing windkessel vascular functions (Figure 3) were monitored 
continuously. The following two indices of brainstem cardio-
vascular regulations: cardiac vagal tone (CVT) representing 
the active beat-to-beat central restraint of chronotropic func-
tion of the heart (Zone C, Figure  3) and cardiac sensitivity 
to baroreflex (CSB) representing the beat-to-beat negative 
feedback baroreflex gain the brainstem is using to regulate 
sympathetic vascular functions (Zone D, Figure 3) were also 
monitored and quantified continuously. We shall refer to CSB 
as beat-to-beat central sympathetic restraint because it is set 
up and frequently updated within the NTS of cVLM in the 
brainstem as previously discussed in Functional Anatomy. All 
the volunteers had normal supine baseline cardiovascular pa-
rameters as follows: MAP (means ± SEM) 84.9 ± 3.2 mmHg; 
HR, 63.9 ± 3.2 beats/min; CVT, 10.8 ± 2.6 LVS units (LVS, 
Linear Vagal Scale (Julu,  1992)) and CSB, 8.2  ±  1.6  ms.
mmHg−1. A progressive orthostatic stress was achieved using 
head-up tilt (HUT) at 60 degrees, followed by a combina-
tion of HUT and lower body suction (LBNP) to achieve pre-
syncope. We defined pre-syncope as a fall in SBP to below 
80 mmHg accompanied by symptoms. All volunteers reached 
this level of cardiovascular decompensation.
The phases of orthostasis
Early Part of Orthostasis in Phase 1. Phase 1 of orthostasis 
has early and late parts. The early part of phase 1 consists of 
several events that provoke readjustments of cardiovascular 
regulations. These events can be illustrated much better in the 
orthostasis during active standing more than during passive 
tilt. We shall therefore use the sequence of events illustrated in 
Figure 1 during active standing to illustrate the readjustments 
of cardiovascular regulation provoked by various events 
during early orthostasis starting with the command to achieve 
an upright stance and follow through to the full cardiovascular 
compensation during the upright stance (from a to f, Figure 1). 
The emphasis of this discussion will be on the regulation of 
heart rate during orthostasis. The command can be internal in 
the form of a decision to stand up or external when a subject 
is asked to stand up from a sitting position like in this example 
(a, Figure  1). The command causes immediate reduction of 
the beat-to-beat baroreflex negative feedback used for central 
sympathetic restraint and quantified as CSB (a, Figure 1), but 
the central restraint of the chronotropic function of the heart 
quantified as CVT is reduced a little later after a time lag 
following the orthostatic command (b, Figure  1). The ramp 
increase in heart rate during the early Phase 1 of orthostasis 
starts simultaneously with CVT withdrawal (b, Figure 1) earlier 
than any voluntary movement of the body at the beginning of 
orthostasis (see body movement artefacts in the blood pressure 
trace, Figure 1) and it ends with the restoration of CVT back 
to a level similar to that at the beginning of CVT withdrawal 
(d, Figure 1). The rebound bradycardia of orthostasis (starting 
from d to e, Figure 1) coincides with additional increases of 
both CSB and CVT exceeding the levels before the orthostatic 
command. Full cardiovascular compensation during which the 
heart rate is stable during orthostasis is achieved within 128 s, 
just over 2 min of actively standing upright in this example 
(starting from c to f, Figure 1).
Takeaway points
1. Cardiovascular arousal is indicated by the beginning of 
withdrawal of baroreflex central sympathetic restraint 
measured here as CSB. It starts at the same time with 
the command to execute orthostasis and precedes all 
other cardiovascular events during the orthostatic process
2. The start of the ramp increase in heart rate during early 
orthostasis coincides with the beginning of withdrawal of 
central chronotropic restraint measured here as CVT. The 
withdrawal of CVT and increase in heart rate precedes any 
body movement during the initiation of orthostasis
3. Changes in heart rate in early orthostasis have three stages; 
a ramp tachycardia followed by rebound bradycardia fol-
lowed by recovery to stable but increased heart rate com-
pared with the supine baseline level. The increase is about 
17% above baseline level, with an average increase of 12 
beats/min and a range of 5 to 25 beats/min above baseline 
level
4. The magnitudes of heart rate changes in early orthostasis 
have been standardized as a 30:15 ratio test and adopted 
for use in clinical examinations of autonomic functions
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5. Full cardiovascular compensation in orthostasis is 
achieved within 3 min of assuming an upright stance. The 
consensus statement on the definition of orthostatic hypo-
tension recommend assessment of postural hypotension at 
three minutes in upright or tilt position
The late part of orthostasis in phase 1. The late part of 
orthostasis Phase 1 starts at full cardiovascular compensation 
(starting from f, Figure  1). However, we shall use the 
example of laboratory-controlled orthostatic stress during 
60 degrees tilt to illustrate full cardiovascular compensation 
during orthostasis. Most healthy people can maintain full 
cardiovascular compensation during orthostasis at 60 degrees 
tilt for more than 20  min. In this example of laboratory-
controlled orthostatic stress, nearly 65% of the volunteers 
maintained full cardiovascular compensation for more than 
20 min at 60 degrees tilt until LBNP was applied to achieve 
laboratory-controlled cardiovascular decompensation. The 
final adjustments of cardiovascular regulation to achieve full 
cardiovascular compensation include increase of windkessel 
vascular resistance (Zone D, Figure  3) to 170% of supine 
baseline level and an upgrade of the chronotropic function of 
the heart (Zone C, Figure 3) to 17% above the supine baseline 
level leading to increase in heart rate by an average of 10 
beats/min among the volunteers. The increased windkessel 
vascular resistance during orthostasis significantly increased 
the diastolic and the mean arterial blood pressure, but it 
did not significantly affect the systolic blood pressure. The 
adjustments of central cardiovascular regulations required 
for achieving full compensation at a slight but significantly 
raised MAP (6% above supine level) during orthostasis 
involve reduction of CVT to 32% and CSB to 33% of the 
supine baseline levels. It means all the parasympathetic 
restraints used for cardiovascular control at 60 degrees tilt 
are reduced to only one-third of the baseline level in supine 
position to achieve full cardiovascular compensation.
Takeaway points
1. The majority of healthy people can maintain full car-
diovascular compensation during orthostasis for more 
than 20  min at 60 degrees tilt
2. The international consensus statement on the definition 
of postural tachycardia syndrome (POTS) recommend 
a sustained heart rate increment of more than 30 beats/
min within 10 min of orthostasis, but without orthostatic 
hypotension as a basis of the diagnosis of the disorder 
(Freeman et al., 2011). Conversely, this is equivalent to 
natural and physiological Phase 2 orthostasis observed in 
all volunteers in a laboratory-controlled progressive or-
thostatic stress to be described later in this review
3. Full cardiovascular compensation during orthostasis is 
achieved by the application of the maximum windkessel 
vascular resistance leaving no reserve for any further and 
additional cardiovascular stress beyond the initial fully 
compensated status. This is equivalent to an all or none 
regulatory strategy in the use of windkessel vascular re-
sistance during orthostasis
4. Full cardiovascular compensation during orthostasis is 
achieved by the reductions of the two central parasympa-
thetic restraints of cardiovascular controls, CSB and CVT, 
to one-third of their baseline supine values. Where CSB 
represents the baroreflex central sympathetic restraint and 
CVT represents the central chronotropic restraint of the 
heart. However, reserve capacity for cardiovascular regu-
lation is still available for use should there be further and 
additional cardiovascular stress beyond the initial fully 
compensated status during Phase 1 orthostasis
Orthostasis phase 2. Abrupt and progressive increase 
in heart rate marks the beginning of Orthostasis Phase 
2 (Figure  4). It follows a period of stable heart rate in the 
late part of Phase 1 of orthostasis with full cardiovascular 
compensation. This is an early sign of severe orthostatic stress 
and can be largely asymptomatic but subjects may experience 
palpitations in the later part of this phase of orthostasis. The 
amplitude of blood pressure variation increases during this 
phase of orthostasis (Figure 4) and there is also a degree of 
overlap between this phase and the next Phase 3 of orthostasis. 
There is a sudden decrease in pulse pressure (measured in 
this example as the difference between beat-to-beat systolic 
and diastolic pressures) toward the end of Phase 2, which 
could be seen in all the volunteers in this example. The 
average duration of Phase 2 orthostasis is 4 min. The heart 
rate will either continue to increase up to the time when both 
blood pressure and heart rate becomes unstable and starts 
oscillating, or would reach a peak where it remains relatively 
stable for the remainder of this orthostatic phase. The heart 
rate reached an average 104 beats/min at the peak among 
volunteers in this phase of orthostasis in this laboratory-
controlled progressive orthostatic stress. This is a significant 
additional 39% increase in the chronotropic function of the 
heart (Zone C, Figure 3) above the level at the late part of 
Phase 1 of orthostasis described above. The central restraint 
of chronotropic function of the heart, represented by CVT in 
this example, was further reduced by a comparable proportion 
of 38% of the level at full cardiovascular compensation in 
the late part of Phase 1 orthostasis. There is a markedly 
significant rise of heart rate to a level that is 63% above the 
supine baseline level, which is an increase of 40 beats/min. 
With the CVT level of 2.2 ± 0.5 LVS units, it is a significant 
reduction by 80% during this phase of orthostasis compared 
with the baseline level in supine position. Interestingly, there 
is no further increase in forearm vascular resistance during 
this phase of orthostasis. There is instead a 16% reduction of 
forearm vascular resistance compared with the level during 
full cardiovascular compensation in the late part of Phase 1 
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from 170% to 144% of supine baseline level toward the end 
of Phase 2 orthostasis. This means the windkessel vascular 
resistance (Zone D, Figure 3) is downgraded by up to 16% 
in Phase 2 orthostasis compared to the level required for full 
cardiovascular compensation without excessive tachycardia 
during orthostasis. This is in spite of a further significant 
56% additional reduction of baroreflex negative feedback 
sympathetic restraint, represented here by CSB, compared 
with the level at full cardiovascular compensation during 
the late part of Phase 1 orthostasis. With the CSB level of 
only 1.2 ± 0.4 ms.mmHg−1 there is in total 85% reduction 
of baroreflex central sympathetic restraint during this phase 
of orthostasis compared with the baseline level in supine 
position. This means all the parasympathetic restraints used 
for cardiovascular control during the severe orthostatic stress 
in Phase 2 orthostasis are reduced to less than 20% of the 
baseline level in supine position. Systolic and mean arterial 
blood pressures decreased by just 8% but with statistical 
significance compared with levels at full cardiovascular 
compensation, but there is no significant change in the 
diastolic pressure during this phase of orthostasis. Therefore, 
it is evident in this example that Phase 2 is a tachycardia phase 
of orthostatic cardiovascular compensation during which 
windkessel vascular resistance is either at the beginning of 
failure or it is being degraded due to metabolic demands. We 
can speculate that probably metabolic demands meant there 
is need for windkessel vascular resistance to be reduced in 
order to increase arterial drainage into tissues because the 
severe orthostatic stress applied during this phase would have 
reduced cardiac output (Zone D, Figure  3). As discussed 
above in Functional Anatomy, both gravity and LBNP do 
reduce cardiac output. Reduced cardiac output will only be 
confirmed as a cause for degrading the windkessel vascular 
resistance in this phase of orthostasis when beat-to-beat 
cardiac output is measured simultaneously with the other 
cardiovascular parameters (Zones C and D, Figure 3). This 
was not done during the laboratory-controlled orthostatic 
stress in this example.
This observation means the chronotropic function of the 
heart (Zone C, Figure 3) takes the main role of cardiovascular 
compensation during orthostasis when the windkessel vas-
cular resistance (Zone D, Figure 3) is failing or is degraded 
for metabolic reasons. This will require bilateral activations 
of chronotropic drive of the heart from the premotor areas of 
the frontal lobes in CARS site 11 (Figure 2) assisted by the 
right posterior insular cortex and the left cerebellum together 
with bilateral and near total withdrawal of chronotropic re-
straints from the amygdala, medial dorsal nucleus of the thal-
amus and the periaqueductal grey matters in the brainstem 
because the extent of this orthostatic stress is equivalent to 
moderate to severe loss of venous return as previously dis-
cussed in Functional Anatomy. The observed effects in this 
F I G U R E  4  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters at the 
transition of orthostasis Phase 1 to Phase 2. Heart rate (HR) expressed in beats.min−1; systolic (SBP), diastolic (DBP) and mean (MAP) arterial 
blood pressures measured in mmHg; cardiac sensitivity to baroreflex (CSB) measured in ms.mmHg−1 and cardiac vagal tone (CVT) measure 
in units of a linear vagal scale (LVS) (see text for descriptions and methods used to measure these cardiovascular parameters). Note the sudden 
onset of sustained and excessive tachycardia coinciding with further reduction of the already very low levels of CSB and CVT at the beginning of 
orthostasis Phase 2
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laboratory-controlled orthostatic stress is the near total re-
moval of the central parasympathetic restraints of cardio-
vascular regulations during which both CVT and CSB are 
reduced to their lowest levels that can support physiological 
functions of the cardiovascular system. This is associated 
with tachycardia at the highest level during the whole period 
of the controlled orthostatic stress. The clinical implication 
of this observation is that the administration of β-adrener-
gic blockers or other centrally acting drugs like clonidine 
for treating the tachycardia of orthostasis must be done with 
caution in case this major and possibly the only compensa-
tory mechanism available to the patient is disabled by drugs 
thereby severely affecting orthostatic tolerance.
Takeaway points
1. Degradation of the windkessel vascular resistance (Zone 
D, Figure  3) by an average of 16% below its maximum 
is a significant event in Phase 2 orthostasis. It triggers 
sudden and sustained tachycardia of the magnitude de-
scribed in POTS
2. This is a tachycardia phase of orthostasis where the 
chronotropic function of the heart (Zone C, Figure  3) 
takes over as the main compensatory mechanism during a 
severe orthostatic stress accompanied by a significant 8% 
drop of MAP below the level in the initial full cardiovas-
cular compensation status
3. The central parasympathetic restraints of cardiovascu-
lar functions, CSB and CVT, are reduced to their lowest 
levels that can sustain stable blood circulation in Phase 
2 orthostasis. The reserve for functional parasympathetic 
withdrawal in cardiovascular control is exhausted in Phase 
2 orthostasis
4. Supramedullary, CARS sites that restrain the chronotropic 
function of the heart (Zone C, Figure  3) in response to 
severe cardiovascular stress involving reduced venous 
return should be at their lowest activities during Phase 2 
orthostasis (see Functional Anatomy for a detailed discus-
sion). The main bilateral sites are the amygdala in CARS 
site 8 and the medial dorsal nucleus of the thalamus in 
CARS site 4 (Figure 2). Both are within the limbic system 
and are assisted by the right periaqueductal grey matter in 
the midbrain in CARS site 7. There is no evidence of in-
appropriate activities in these CARS sites during Phase 2 
orthostasis because the magnitudes of both CSB and CVT 
stayed at their lowest as expected
5. The supramedullary CARS sites that actively increase the 
windkessel vascular resistance (Zone D, Figure 3) in re-
sponse to severe cardiovascular stress involving reduced 
venous return have a reduced effectiveness in Phase 2 or-
thostasis below the level required for full cardiovascular 
compensation. The main bilateral sites are the premotor 
areas of the frontal lobes in CARS site 11 restrained and 
modulated by the anterior insula cortices within the limbic 
system in CARS site 8 (Figure  2). The activities of all 
these CARS sites are monitored closely by the precuneus 
cortex that normally processes self-consciousness (see 
Functional Anatomy)
Orthostasis phase 3. This phase is symptomatic presenting 
with very early evidence of pre-syncope like dizziness and 
is characterized by exaggerated oscillations of both arterial 
blood pressures and heart rate (Figure 5). Phase 3 tends to 
overlap with Phase 2 orthostasis. The average amplitude 
of the oscillations of systolic blood pressure is 27 mmHg 
with a period of oscillations of about 10 s (a frequency of 
0.1 Hz). This is known as Traube–Hering–Mayer's waves 
(Julu et  al.,  1997; Sato,  1951). This is the mammalian 
cardiovascular natural resonance frequency caused by the 
feedback controls in the cardiovascular regulatory circuit 
(DeBoer, Karemaker, & Strackee, 1987). Traube–Hering–
Mayer's waves can be recorded in mammals of various 
sizes under various conditions, for example, in humans 
(Delamont, Julu, & Jamal,  1999; Julu et  al.,  1997 ), in 
dogs (Little & Julu,  1995) or even in mice (Bumstead, 
Bauer, Wright, & Culver,  2017). The average values of 
systolic blood pressure during these oscillations actually 
do increase above the values observed during Phase 2 
orthostasis. Heart rate is significantly less than it is during 
Phase 2 orthostasis with an average of 98 beats/min, It is 
6% lower than its average peak in Phase 2 orthostasis but 
it is still significantly higher than the heart rate at baseline 
in supine position (Julu et al., 2003). The average duration 
of Phase 3 orthostasis is 2  min. Central cardiovascular 
regulation during Phase 3 orthostasis is not very different 
from that during Phase 2. The average value of CVT during 
this phase is 2.1 LVS units and average value of CSB is 
1.3  ms.mmHg−1, not significantly different from that 
during Phase 2 orthostasis. It is therefore evident that the 
chronotropic function of the heart (Zone C, Figure 3), which 
has a major compensatory role in Phase 2, is beginning 
to be degraded or to fail in Phase 3 orthostasis. We can 
speculate here that it is the sympathetic chronotropic drives 
from the premotor areas of the frontal lobes assisted by 
the posterior insula cortex and the cerebellum that are 
selectively reduced in Phase 3 compared with the levels 
in Phase 2 orthostasis without any alteration of the levels 
of the limbic and midbrain parasympathetic restraints. 
This is because the levels of both CVT and CSB are kept 
at their lowest in this orthostatic phase, comparable to the 
levels in Phase 2 orthostasis. This means cardiovascular 
functions in both Zones C and D (Figure 3) are beginning 
to be either degraded or to fail during Phase 3 orthostasis. 
Both CVT and CSB, the two central parasympathetic 
restraints of cardiovascular regulations are kept at their 
lowest levels in response to this severe orthostatic stress 
in Phase 3 Orthostasis (Figure 5). The large amplitude of 
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blood pressure oscillation suggests that there is insufficient 
dumping effect in the feedback control circuit of blood 
circulation. It means the levels of both CSB and CVT are too 
low to sustain stable blood circulation during the combined 
sub-optimal chronotropic drive and windkessel vascular 
resistance in Phase 3 orthostasis. The clinical significance 
of this observation is mainly to raise awareness so that 
practitioners do appreciate the very important role of the 
natural central parasympathetic restraints of cardiovascular 
functions in maintaining sustainable and stable blood 
circulation in both healthy people and in patients.
Takeaway points
1. Degradation of the chronotropic function of the heart is 
a major event in Phase 3 orthostasis. It triggers exagger-
ated oscillations of both arterial pressure and heart rate 
at 0.1  Hz. Cardiovascular oscillation at this frequency 
is known as Traube–Hering–Mayer's waves present in 
all mammals irrespective of body size
2. Windkessel vascular resistance and chronotropic function 
of the heart are both at sub-optimal levels that is insuffi-
cient for defending and preventing oscillations of arterial 
blood pressure during the severe cardiovascular stress in 
Phase 3 orthostasis
3. The drop in heart rate alone without effects on windkes-
sel vascular resistance, CVT and CSB means the central 
sympathetic chronotropic drive to the heart (Zone C, 
Figure 3) can be, and is selectively degraded during Phase 
3 orthostasis. Levels of CVT and CSB representing central 
parasympathetic restraints of cardiovascular control are 
kept at their lowest in Phase 3 comparable to that in Phase 
2 orthostasis. This illustrates the flexibility provided by 
the organotopic neurons in CARS sites for independent 
adjustments of various individual functions during cardio-
vascular regulation
4. The natural central parasympathetic restraints play major 
roles in maintaining stable circulation of blood. These re-
straints can be quantified using validated clinical units. 
The average CVT level of 2.2 ± 0.5 LVS units and the 
average CSB level of 1.4 ± 0.3 ms.mmHg−1 are the low-
est levels of central parasympathetic restraints that can 
sustain stable blood circulation during severe orthostatic 
stress in the population sample used here in this example 
of laboratory-controlled progressive orthostatic stress
Orthostasis phase 4. This is a phase of cardiovascular 
decompensation under severe orthostatic stress and it 
includes the resetting of central cardiovascular regulatory 
parameters to facilitate recovery from the cardiovascular 
decompensation. It starts with sudden decreases in arterial 
blood pressure and heart rate and is associated with 
intensification of symptoms of pre-syncope including the 
F I G U R E  5  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters at the 
transition of orthostasis Phase 2 to Phase 3. Heart rate (HR) expressed in beats.min−1; systolic (SBP), diastolic (DBP), and mean arterial blood 
pressures (MAP) measured in mmHg; cardiac sensitivity to baroreflex (CSB) measured in ms.mmHg−1 and cardiac vagal tone (CVT) measure 
in units of a linear vagal scale (LVS) (see text for descriptions and methods used to measure these cardiovascular parameters). Note the clearly 
demarcated border of increased amplitude of oscillations of blood pressure and heart rate at the beginning of orthostasis Phase 3 without any further 
changes in the already very low levels of CSB and CVT. The period of blood pressure oscillation is 10 s (frequency of 0.1 Hz)
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loss of spatial awareness and may lead to postural syncope. 
The runaway drop in blood pressure precedes bradycardia 
by an average of 23  s in the majority of subjects (71%) in 
this laboratory-controlled orthostatic stress and it is 11  s 
before the beginning of bradycardia in the illustration below 
(Figure  6). Reduction of forearm vascular resistance from 
the full cardiovascular compensation level of 170% to 137% 
of the supine baseline level represents a drop in windkessel 
vascular resistance (Zone D, Figure 3) to a level that can no 
longer defend and sustain a viable arterial blood pressure 
during the severe orthostatic stress in Phase 4 orthostasis. It 
therefore triggers a runaway fall in arterial blood pressure in 
Phase 4 orthostasis described as a vasodepressor response 
(Figure 6). The need for downgrading the level of windkessel 
vascular resistance is to try and compensate for the continual 
reduction of venous return (Zone D, Figure 3) caused by the 
combined effects of gravity and the continual LBNP being 
applied in this laboratory-controlled example. Downgrading 
windkessel vascular resistance could be regarded as 
facilitation of arterial drainage into tissues to compensate for 
the reduced cardiac output caused by reduced venous return. 
The anterior insular cortex in CARS site 8 and the anterior 
Cingulate cortex in CARS site 6 (Figure 2), both are within 
the limbic system, and the premotor area of the frontal cortex 
in CARS site 11 would be the prominent supramedullary 
CARS sites (Figure  3) involved in the modulation and 
restraint of autonomic commands to the windkessel vessels 
to counteract the effects of the loss of venous return. This has 
been discussed before in detail in Functional Anatomy.
The collapse of arterial blood pressure during the vaso-
depressor response in Phase 4 orthostasis triggers a reset of 
the central restraint of the chronotropic function of the heart 
(Zone C, Figure 3) after a brief delay, leading to a rapid in-
crease in the level of CVT (Figure  6). This rapid increase 
in the level of CVT coincides with a rapid bradycardia de-
scribed as a cardiodepressor response in Phase 4 orthostasis 
(Figure 6). The rapid rise of CVT during the cardiodepressor 
response in Phase 4 orthostasis is withdrawn back to lower 
levels almost immediately once blood pressure recovery is 
initiated (Figure 6). The amygdala in CARS site 8 and the 
medial dorsal nucleus of the thalamus in CARS site 4, both 
are within the limbic system, and the periaqueductal grey 
matters in CARS site 7 in the midbrain (Figure 2) would be 
the prominent supramedullary CARS sites (Figure 3) in mod-
ulating the restraint of the chronotropic function of the heart 
in response to reduced venous return. This is discussed in 
more detail in Functional Anatomy. The reset and upgrade of 
CSB are not critical, therefore the timing of its execution is 
F I G U R E  6  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters at the 
transition from orthostasis Phase 3 to Phase 4. Heart rate (HR) expressed in beats.min−1; systolic (SBP), diastolic (DBP), and mean arterial blood 
pressures (MAP) measured in mmHg; cardiac sensitivity to baroreflex (CSB) measured in ms.mmHg−1 and cardiac vagal tone (CVT) measure 
in units of a linear vagal scale (LVS) (see text for descriptions and methods used to measure these cardiovascular parameters). Note the sudden 
and progressive decrease in blood pressure at the beginning of a vasodepressor response at (a). This was followed 11 s later by a progressive 
bradycardia starting at (b) in a cardiodepressor response. The bradycardia in the cardiodepressor response coincides with the beginning of a sudden 
rise of CVT at (c) during which CVT is reset from its very low level to an exaggerated high level. CSB was reset much later at (d) (see text for full 
explanation)
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flexible during Phase 4 orthostasis. It can precede the CVT 
reset or lag behind it (Julu et al., 2003).
The rapid reset of CVT from its lowest to a high level in 
order to restrain the chronotropic function of the heart is es-
sential for the initiation of blood pressure recovery in Phase 4 
orthostasis. The clinical implication is that some practitioners 
use cardiac pacing to prevent the cardiodepressor response 
in Phase 4 orthostasis with the aims of treating postural syn-
cope. This often fails to work because although a cardiac 
pacemaker can prevent the cardiodepressor response, it does 
not affect the vasodepressor response in Phase 4 orthostasis 
(Figure 7). Moreover, by preventing the cardiodepressor re-
sponse during Phase 4 orthostasis, blood pressure recovery 
is abolished because cardiac pace makers artificially remove 
the natural means of initiating recovery and the blood pres-
sure stays low (Figure 7). The patient remains symptomatic 
with evidence of deterioration of orthostatic tolerance with 
poor and delayed recovery following syncope.
Takeaway points
1. Progressive orthostatic stress induced by a combina-
tion of gravity and LBNP causes progressive decrease 
of the windkessel vascular resistance from the highest 
achievable level in Phase 1 to the lowest level at the 
beginning of Phase 4 orthostasis
2. Levels of windkessel vascular resistance less than 140% 
above the supine baseline level triggers vasodepressor 
response during orthostasis at low parasympathetic tone. 
Vasodepressor response is characterized by a runaway 
drop of arterial blood pressure associated with pre-syn-
cope symptoms. The drop in arterial blood pressure is in-
dependent of heart rate and occurs in people with paced 
hearts
3. Vasodepressor response in Phase 4 orthostasis triggers 
a rapid increase in CVT from its very low level after an 
average lag time of 23 s in majority of cases. The rapid 
increase in CVT coincides with a rapid decrease in heart 
rate described as a cardiodepressor response
4. The cardiodepressor response in Phase 4 orthostasis is 
characterized by a rapid and continuous decrease of heart 
rate. This can lead to asystole lasting below 5 s in less than 
15% of cases
5. The rapid increase of CVT and the associated car-
diodepressor response are essential for natural and 
quick recovery of arterial blood pressure from the 
vasodepressor response caused by orthostatic stress. 
Prevention of both CVT rise and the associated car-
diodepressor response using cardiac pacing abolishes 
the natural and quick recovery from orthostatic vaso-
depressor response
F I G U R E  7  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters at the 
transition from orthostasis Phase 3 to Phase 4 in a patient with a paced heart. Heart rate (HR) expressed in beats.min−1; systolic (SBP), diastolic 
(DBP) and mean (MAP) arterial blood pressures measured in mmHg; cardiac sensitivity to baroreflex (CSB) measured in ms.mmHg−1 and cardiac 
vagal tone (CVT) measure in units of a linear vagal scale (LVS) (see text for descriptions and methods used to measure these cardiovascular 
parameters). Note the blood pressure drop starting at (a) without any change in the paced heart rate in a vasodepressor response during tilt test 
associated with symptoms of pre-syncope. The tilt test was abandoned at (b) to allow the blood pressure to recover
   | 21 of 29OKETA-ONYUT JULU
1.4.5 | The physiological basis of 
postural orthostatic tachycardia
The international consensus statement on the definition of 
POTS is based on the magnitude of the tachycardia plus one 
other requirement of no change in arterial blood pressure that 
can be defined as postural hypotension. They also gave a 
definition of postural hypotension in this statement (Freeman 
et al., 2011). Our model (Figure 3) indicates that tachycardia, 
which represents the chronotropic function of the heart in the 
model, is just one of four independent cardiovascular func-
tions that are regulated directly by organotopic neurons in the 
brain and in the brainstem (see Functional Anatomy) to de-
fend arterial blood pressure. These cardiovascular functions 
shown in zones C and D (Figure 3) can be adjusted indepen-
dently to defend the appropriate arterial blood pressure suit-
able for the prevailing physiological state. This was clearly 
illustrated during the laboratory-controlled progressive or-
thostatic stress discussed above. It means if any one of these 
functions should fail, or is sub-optimal, then the other three 
are adjusted accordingly to achieve the required blood pres-
sure. This means the orthodox measurements of heart rate 
and blood pressure during orthostasis on their own will not 
give us any indication of possible pathophysiology of exces-
sive tachycardia observed during clinical tests.
It is however clear from our model that both inotropic 
and chronotropic efforts of the heart are required to trans-
form the venous return into cardiac output. These two cardiac 
functions are complementary to each other and are regulated 
independently by specific organotopic neurons in the caudal 
ventrolateral medulla (cVLM, see Functional Anatomy). It 
means either of the two functions can fail independently or 
any one of them can be used independently to compensate for 
failures of any other cardiovascular functions in zones C and 
D (Figure  3). This means excessive orthostatic tachycardia 
could be compensatory to poor or failing inotropic function 
of the heart, or failure of any other cardiovascular functions 
in zone D (Figure 3). It is also clear from the model that the 
extent of the arterial blood drainage away from the windkes-
sel vessels regulated by the windkessel vascular resistance 
together with the cardiac output into the windkessel vessels 
determines the arterial blood pressure. Excessive orthostatic 
tachycardia could be compensatory to failure of either or both 
of these cardiovascular functions in zone D (Figure 3). We 
have used in our laboratory a combination of gravity and me-
chanical manipulation of venous vascular capacitance using 
LBNP to progressively change the level of venous return and 
mimic a few of the pathophysiology of POTS.
It is evident from the description of the physiology of or-
thostatic tachycardia using our model (Figure 3) that standard-
ized and validated clinical methods for assessing individual 
cardiovascular functions in zones C and D in addition to the 
orthodox measurements of blood pressure and heart rate are 
required. There is also need to quantify if possible the cen-
tral autonomic regulation of these cardiovascular functions. 
Advances in medical technology have enabled the quantifi-
cation of central parasympathetic cardiovascular control and 
few other surrogate measures of the cardiovascular functions 
in zones C and D (Figure 3) and they are reviewed below.
1.5 | Recommended neurophysiological 
assessments in a clinical laboratory 
to identify the pathophysiology of 
postural orthostatic tachycardia syndrome
1.5.1 | Autonomic target-organs 
neurophysiological tests (ATONT)
Definition of autonomic failure
The phrase “Autonomic Failure" when used as a clinical term 
means the inability of the autonomic nervous system to exe-
cute co-ordinated and standardized autonomic tasks that have 
been identified and validated for clinical examinations of the 
system. The autonomic tasks are set up in the form of spe-
cial maneuvers recommended for clinical tests of autonomic 
function by an International Committee in a consensus state-
ment of San Antonio (Kahn, 1988). Diagnosis of autonomic 
failure cannot be based on a single abnormal test parameter 
because the autonomic nervous system either influences or 
controls the functions of all the organs in the body. It requires 
a set of carefully designed clinical maneuvers aimed to ex-
amine functions of specific target-organs in order to draw 
conclusions whether or not such target-organs have normal 
functions. We have designed and validated multiple param-
eters described below. Some of these are derived from the 
internationally recommended maneuvers mentioned above 
and some are improvements of the recommendations, but we 
have designed some entirely in our laboratory to diagnose 
and characterize autonomic failures according to the specific 
target-organs we intend to examine. We would report a fail-
ure or dysfunction of a target-organ if its function lies outside 
the range of our normal values. Our laboratory standards are 
based on 250 healthy subjects aged between 13 and 79 years.
Assessment of central parasympathetic function
Resting supine cardiac vagal tone (CVT). This is a measure 
of the central parasympathetic restraint of the chronotropic 
function of the heart (Zone C, Figure 3) that comes through 
the vagus nerve (A, Figure 3). It is measured continuously 
on beat-to-beat basis as “pulse-synchronized phase shifts in 
consecutive cardiac cycles” using the NeuroScope (Medifit 
Instruments Ltd, London, UK) in a quiet room at controlled 
room temperature of 21 ± 1°C. It is essentially a form of jitter 
that is quantified continuously from the electrocardiogram 
(ECG) using a circuit of electronic integrators and phase 
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detector to convert the pulse interval jitters into voltages 
(Little, Julu, Hansen, & Reid,  1999), which are then 
calibrated into units of the atropine-derived linear vagal 
scale (LVS (Julu, 1992)). The least value in the units of LVS 
is zero, equivalent to full atropinization of human subjects 
(Julu, 1992). The LVS is therefore a validated clinical unit of 
cardiac vagal tone with an absolute zero reference point. The 
frequency distribution of CVT measured in units of LVS in 
our laboratory control population is approximately Gaussian 
(Figure 8).
Respiratory gating of cardiac vagal tone (CVT) In supine 
position. The central parasympathetic tone with inherent 
cardiac pulse and breathing rhythms and responds to voluntary 
changes in breathing rhythms is also known as cardiac vagal 
tone and it is generated by cardiac vagal premotor neurons 
(cVPN) in the nucleus ambiguus (NA) in the brainstem as 
discussed previously in Functional Anatomy. The magnitude 
of respiratory gating of CVT at the level of cVPN in NA can 
be quantified (Figure 9) and used to assess the integrity of 
cardiorespiratory neurons within the brainstem. This is a 
central cardiorespiratory cholinergic function of the brainstem 
at the level of cVPN (Gilbey et al., 1984). Lying in supine 
position, the subject is asked to take a deep breath lasting 
4 s and to breathe out forcefully and reach up to expiratory 
reserve volume within 6  s and repeating this exercise six 
times while CVT is being measured continuously (Figure 9) 
using the NeuroScope (Medifit Instruments Ltd, London, 
UK) in a quiet room with controlled room temperature as 
described above. Deep breathing at 0.1 Hz should increase 
CVT from baseline (Figure  9) by values ranging between 
5 and 15 LVS units and should show clear respiratory 
modulations (Figure 9) in the continuous CVT record at the 
same frequency (Our laboratory standard).
Resting Supine Cardiac Sensitivity to Baroreflex 
(CSB). This is a measure of the beat-to-beat baroreflex 
central sympathetic restraint exerted directly within the 
brainstem (see Functional Anatomy). It is a measure of the 
well-known baroreflex restraint of sympathetic activity, 
mainly the vasomotor tone in the RVLM, and the baroreflex 
restraint is coming through the NTS (Dampney,  2009; 
Schreihofer & Guyenet,  2002). The resting supine CSB 
is measured using the NeuroScope (MediFit Instruments 
Ltd, London) as previously described (Julu et al., 2003) in 
a quiet room at controlled room temperature as described 
above. The index is defined as the increase in pulse interval 
per unit increase in systolic pressure and it is measured in 
units of ms.mmHg−1. It is a beat-to-beat baroreflex negative 
feedback control of arterial blood pressure. The least 
value of CSB is zero representing no negative feedback 
cardiovascular control at all. The normal range in our 
laboratory population is between 6 and 12  ms.mmHg−1. 
The 95% confidence interval in the population sample used 
in the progressive orthostatic stress study described here in 
this review is between 5 and 11 ms.mmHg−1 similar to our 
laboratory normal range. The method allows the detection 
of rapid changes in CSB within a continuous measurement, 
which represents real-time engagements and disengagements 
of the baroreflex negative feedback cardiovascular control. 
Disengagement of negative feedback cardiovascular control 
indicates cardiovascular arousal in preparation for imminent 
changes in either blood pressure alone, or heart rate alone 
(Figure 1), or both heart rate and blood pressure at the same 
time (Figure 1).
Assessment of central baroreflex gain. We use the 
isometric contraction of the skeletal muscles of the dominant 
hand during a sustained handgrip at 50% of the maximum 
sustainable force measured in Newton (N) for a target 
duration of three minutes to reduce and keep the baroreflex 
negative feedback cardiovascular restraint to its lowest level 
(Figure 10). Withdrawal of the baroreflex negative feedback 
F I G U R E  8  A frequency distribution plot of the observed 
values of cardiac vagal tone (CVT) measured in units of a linear 
vagal scale (LVS) at rest in supine position in the laboratory control 
population (n = 250, see text for details). The theoretical statistical 
Gaussian distribution with the same population mean and standard 
deviation is superimposed in this plot. Chi squared test showed a 
normal distribution of CVT in our laboratory control population. The 
laboratory normal range of resting supine values of CVT is indicated 
in the plot together with the 95% confidence interval of baseline 
CVT values in a sample population used in the study of the effects 
of progressive orthostatic stress on autonomic regulation of the 
cardiovascular system (see text for details)
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control measured as CSB in the upright-seated position is 
achieved within 1  min of sustained handgrip and stays at 
its least level for the remaining duration of the handgrip. 
This is confirmed visually on the computer screen during 
the test procedure (Figure 10). Since CSB is at its lowest 
level, the gradients of the concurrent slow and sustained 
rise in heart rate and arterial blood pressure during the 
second and third minute of sustained handgrip (Figure 10) 
are regulated by the supramedullary CARS sites (Figure 3). 
The periorbital frontal lobes in CARS site 9 (Figure  2) 
are the dominant bilateral supramedullary CARS sites 
during the restraints of both heart rate and arterial blood 
pressure during isometric contraction of skeletal muscles as 
previously discussed in Functional Anatomy. The gradient 
of concurrent changes in heart rate and arterial blood 
pressure is a measure of baroreflex gain and in this case 
it is a supramedullary central gain. We define this central 
baroreflex responsiveness (BRR) or gain as the absolute 
value of the ratio ΔR-R/ΔSBP, where ΔR-R is the change 
in the electrocardiographic (ECG) R-R interval, associated 
and concurrent with ΔSBP the change in systolic BP from 
baseline to the respective levels at the end of three minutes 
of sustained handgrip. The central baroreflex gain can be 
predicted from a mathematical equation (Julu, Hansen & 
Jamal, 1996): BRR = 2.42 × 10(3h-5) ms.mmHg−1, where h 
is the subject's height in meters, or can be expressed in terms 
of the natural number “e” where BRR  =  6.35  ×  10(eh-5)  
ms.mmHg−1. The observed value from the ratio ΔR-R/
ΔSBP should be within 50% of the predicted value in the 
age group 15–79 years (Our laboratory standard). The ECG 
R-R intervals, CSB and the arterial blood pressure are 
monitored and measured continuously (Figure 10) using the 
NeuroScope during this assessment of the central baroreflex 
gain (Figure 12).
Assessment of Peripheral baroreflex function
Mechanical digital massage of the carotid sinus. Carotid 
massage using digital pressure applied on the carotid sinus 
in a resting supine position at the rate of the subject's own 
heartbeats for the duration of 15 s should cause an increase 
in the CVT (Figure 11), usually of the magnitudes between 
5 and 20 LVS units above the baseline level in the age group 
15–79 years (our laboratory standard). We describe this as 
a standardized clinical measure of cardiodepressor response 
of peripheral baroreflex accompanied by a sharp drop in the 
heart rate (Figure  11). The same carotid massage should 
cause a drop of systolic arterial blood pressure by at least 
10 mmHg (Figure 11), but should not exceed 30 mmHg (our 
laboratory standard). The CVT and the arterial blood pressure 
are monitored and measured continuously (Figure 11) using 
the NeuroScope (Figure  12) during this assessment of the 
baroreflex function.
F I G U R E  9  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters during 
slow deep breathing at 0.1 Hz. Heart rate (HR) expressed in beats.min−1; systolic (SBP), diastolic (DBP) and mean (MAP) arterial blood pressures 
measured in mmHg; cardiac sensitivity to baroreflex (CSB) measured in ms.mmHg−1 and cardiac vagal tone (CVT) measure in units of a linear 
vagal scale (LVS) (see text for descriptions and methods used to measure these cardiovascular parameters). Note the sharp rise in CVT coinciding 
with the first deep breath and displaying clear respiratory modulation and habituation during subsequent deep breaths. This is associated with 
respiratory sinus arrhythmia (RSA) with the HR oscillating at 0.1 Hz
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Pharmacological peripheral baroreceptor excitation. Intra-
venous injection of phenylephrine or other α1-adrenergic 
vasoactive drugs in a resting supine position should cause a 
concurrent rise in both blood pressure and ECG R-R intervals 
and the two should be statistically associated with a gradient of 
R-R intervals rise per systolic blood pressure rise between 5 and 
12 ms.mmHg−1 (similar to the normal range of the resting supine 
CSB described above) and a correlation coefficient greater than 
0.9 (Our laboratory standard). The ECG R-R intervals and the 
arterial blood pressure are monitored and measured continuously 
using the NeuroScope (Figure  12) during this assessment of 
peripheral baroreflex function.
Assessment of sympathetic α1-Adrenergic Denervation 
Hypersensitivity
A small intravenous bolus dose of 25 μg of phenylephrine is 
used to test for denervation hypersensitivity of sympathetic 
α1-adrenergic nerves. This will cause systolic blood pressure 
rise of more than 15 mmHg in denervation hypersensitivity 
(our laboratory standard). All the arterial blood pressures; 
SBP, DBP and MAP, including the parasympathetic re-
straints; CSB and CVT and the heart rate are monitored and 
measured continuously during this test using the NeuroScope 
(Figure 12).
Assessment of sympathetic control of cardioaccelerator 
function
We use the isometric contraction of the skeletal muscles of the 
dominant hand during a sustained handgrip at 50% of the maxi-
mum sustainable force measured in Newton (N) for the duration 
of 3 min to reduce and keep the baroreflex negative feedback car-
diovascular restraint and the central parasympathetic tone to their 
lowest levels (Figure  10). Withdrawals of both the baroreflex 
negative feedback control measured as CSB and the central para-
sympathetic activity measured as CVT within the first minute 
of sustained handgrip mean that the continual increase in heart 
rate during the second and third minute of sustained handgrip 
(Figure 10) represents the central sympathetic drive of cardio-
accelerator function (Pathway B, Figure 3) with minimal para-
sympathetic restraint (Pathway A, Figure 3; see also Functional 
Anatomy). The heart rate should increase above the resting pre-
exercise value (before H1, Figure 10) by 22% to 45% at the end 
of 3 min of sustained handgrip (at H2, Figure 10) in subjects aged 
15–79 years (Our laboratory standard). Beat-to-beat heart rate, 
F I G U R E  1 0  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters 
during sustained isometric contraction of skeletal muscles of the dominant hand for 3 min. Heart rate (HR) expressed in beats.min−1; systolic 
(SBP), diastolic (DBP) and mean (MAP) arterial blood pressures measured in mmHg; cardiac sensitivity to baroreflex (CSB) measured in 
ms.mmHg−1 and cardiac vagal tone (CVT) measure in units of a linear vagal scale (LVS) (see text for descriptions and methods used to measure 
these cardiovascular parameters). Note the withdrawal of both CVT and CSB early at the beginning of muscle contraction, which starts at H1 and 
the levels are maintained at minimum until the end of muscle contraction at H2. This is accompanied by sustained and concurrent increases of both 
HR and all the arterial blood pressures. There was abrupt and exaggerated reset of both CVT and CSB to very high levels at the end of muscle 
contraction at H2 associated with oscillations and immediate and sharp decreases of heart rate and blood pressures back to baseline pre-exercise 
levels
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the arterial blood pressures; SBP, DBP and MAP, including the 
parasympathetic restraints; CSB and CVT are monitored and 
measured continuously (Figure 10) using the NeuroScope during 
this test (Figure 12).
Assessment of sympathetic vasomotor control of 
windkessel vascular resistance
We use the isometric contraction of the skeletal muscles of the 
dominant hand described above to reduce and keep the barore-
flex negative feedback cardiovascular restraint and the central 
parasympathetic tone to their lowest levels in this procedure. 
The continual increase in diastolic blood pressure (DBP) during 
the second and third minute of sustained handgrip represents 
the central sympathetic vasomotor drive of the windkessel 
vascular resistance (Zone D, Figure 3) with minimal parasym-
pathetic restraint (see full discussion in Functional Anatomy). 
We use the rising DBP during sustained handgrip as a sur-
rogate of increasing central sympathetic vasomotor drive to 
windkessel vascular resistance because DBP has a linear re-
lationship with muscles sympathetic nerve activity during this 
procedure (Halliwill, Taylor, & Eckberg, 1996). Diastolic ar-
terial blood pressure is a function of the windkessel vascular 
resistance (Westerhof, Lankhaar, & Westerhof,  2009). The 
skeletal muscle vascular bed provides most of the windkes-
sel vascular resistance during muscle contraction because 
the sympathetic drive to skin is significantly inhibited (see 
Functional Anatomy above) and sympathetic drive to the 
splanchnic vascular bed is mainly to regulate venous vascular 
capacitance (Greenway, 1983) out of the three major vascu-
lar beds used for arterial blood pressure control (Figure 2 and 
Figure 3). The diastolic blood pressure should increase above 
the resting pre-exercise level (before H1, Figure 10) by no less 
than 15 mmHg in all adults (Ewing, Irving, Kerr, Wildsmith, 
& Clarke, 1974) at the end of 3 min (at H2, Figure 10). Our 
laboratory range for the age range 15–79 years is an increase 
above the pre-exercise level by 18–46 mmHg at the end of 
three minutes of sustained handgrip at 50% of the maximum 
sustainable force measured in Newton. All the arterial blood 
pressures; SBP, DBP and MAP, including the residual para-
sympathetic restraints; CSB and CVT and the heart rate are 
monitored and measured continuously (Figure 10) during this 
test using the NeuroScope (Figure 12).
Assessment of sympathetic control of venous vascular 
capacitance in the splanchnic region
We use a positive intra-thoracic pressure of 40 mmHg last-
ing 15  s during Valsalva's maneuver to suddenly reduce 
venous return to the heart (Zone D, Figure 3) and provoke 
an auto-transfusion response (Lundgren,  1983). The auto-
transfusion is caused by a neurogenic constriction of vessels 
F I G U R E  1 1  A computer screen capture from the NeuroScope displaying the following beat-to-beat traces of cardiovascular parameters 
during two episodes of mechanical digital massages of the two carotid sinuses. Heart rate (HR) expressed in beats.min−1; systolic (SBP), diastolic 
(DBP) and mean (MAP) arterial blood pressures measured in mmHg; cardiac sensitivity to baroreflex (CSB) measured in ms.mmHg−1 and cardiac 
vagal tone (CVT) measure in units of a linear vagal scale (LVS) (see text for descriptions and methods used to measure these cardiovascular 
parameters). The right carotid sinus was massaged for 15 s starting from C1 to C2 at R. Note the sharp increases in both CVT and CSB from 
baseline levels accompanied by sharp drops in both HR and arterial blood pressures. The procedure is repeated on the left carotid sinus at L with 
similar increases in CVT and CSB accompanied by sharp drops in HR and arterial blood pressures.
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and organs in the splanchnic region. In order to optimize the 
assessment of venous return from the splanchnic region, the 
Valsalva's maneuver is performed in the upright-seated posi-
tion with the subject stooping forward so that the inguinal 
ligaments compress the iliac veins to eliminate most of the 
venous return from the lower limbs. Before the auto-trans-
fusion response, arterial blood pressure increases suddenly 
in a Phase I response, then it starts to fall rapidly due to lack 
of venous return in the early part of Phase IIe. The trough 
of SBP in Phase IIe should be within 25  mmHg from the 
pre-maneuver baseline level to indicate adequate and normal 
venous return during the positive intra-thoracic pressure (Our 
laboratory standard). Phase IIe is arrested at the beginning of 
the auto-transfusion response, which starts to restore arterial 
blood pressure back toward the pre-maneuver level during 
the positive intra-thoracic pressure in the late Phase IIi. This 
should end with SBP at or not more than 15 mmHg above 
the pre-maneuver baseline level to indicate adequate auto-
transfusion response (Our laboratory standard). Abrupt end 
of the positive intra-thoracic pressure of Valsalva's maneuver 
reverses the pressure from positive to negative intra-thoracic 
creating a suction effect in Phase III, which decreases the ar-
terial blood pressure suddenly and the SBP at the trough of 
Phase III should be within 25 mmHg from the pre-maneuver 
baseline level to indicate sufficient venous blood volume 
during negative intra-thoracic suction following the auto-
transfusion response (Our laboratory standard). All the ar-
terial blood pressures; SBP, DBP, and MAP, including the 
parasympathetic restraints; CSB and CVT and the heart rate 
are monitored and measured continuously during this test 
using the NeuroScope (Figure 12).
CONFLICT OF INTEREST
I am the inventor of the NeuroScope, but the machine 
is patented by the University of Glasgow in the United 
Kingdom. The University sold the sole right of exploita-
tion of the patent to Medifit Instruments Limited, London, 
the United Kingdom. I have no financial connection with 
this company but sometimes give them scientific advice 
without pay.
F I G U R E  1 2  A schematic representation of non-invasive continuous streams of biometrics obtained from the human body by the NeuroScope 
during the assessment of autonomic functions. Continuous electrocardiogram (ECG) is recorded using three chest-electrodes in a modified 
Einthoven’s triangle, but configured within the NeuroScope as Einthoven's ECG lead II. Continuous stream of breathing movements is recorded 
using respiration impedance plethysmography (RIP), which is coupled within the NeuroScope to facilitate the discrimination and identification 
of apneusis, apnea, Valsalva's maneuvers and other respiratory dysrhythmias. The respiration plethysmogram belt is applied around the chest at 
the xiphisternal level to capture both thoracic and upper abdominal movements. Transcutaneous blood gases are recorded continuously during 
autonomic assessment using the dual oxygen and carbon dioxide electrode (Radiometer, Copenhagen). The transcutaneous blood gases electrode 
measures tension of gases in tissues, not gas tension in the bloodstream. The tension of gases in the tissues correlates with local capillary blood 
flow, tissue metabolism and temperature, all of which are influenced by the autonomic nervous system and form part of autonomic functions. 
Tissue temperature in the surrounding of the transcutaneous blood gases sensor is kept constant using a heating element within the sensor. In 
our practice, the sensor is placed sub-costal in the mid clavicular line close to the liver where it is relatively warmer than other peripheral sites. 
Continuous stream of arterial blood pressure waveform is recorded from the finger using photoplethysmography and Penáz's principle of arterial 
pressure unloading through volume-clamp (Finapres Medical Systems, Enschede the Netherlands). All biometrics are synchronized to the nearest 
millisecond, date and time-stamped before they are used to derive cardiovascular and autonomic parameters using the VaguSoft software (Medifit 
Instruments Ltd, London).
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